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9Abstract
Cystic fibrosis (CF) is an autosomal recessive disease, caused by mutations in the gene
encoding the cystic fibrosis transmembrane conductance regulator (CFTR), a
phosphorylation –regulated Cl- channel expressed in the apical membrane of epithelia,
and is characterised by pathological features of variable severity. Isolation of the murine
homologue (Cftr) of the human gene enabled the development of transgenic cystic
fibrosis mouse models. Using insertional mutagenesis in Cftr exon 10 Dorin et al., 1992
developed the CftrTgH(neoim)Hgu mouse model of CF. A pair of homozygous CftrTgH(neoim)Hgu
animals with a mixed genetic background became the founders for the generation of two
inbred CftrTgH(neoim)Hgu strains CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu. In the
context of this thesis these two inbred CF strains were both genetically and
phenotypically characterised. Biochemical and functional analysis of the two strains
revealed that, unlike their progenitors with a mixed genetic background, trace amounts
of correctly spliced mRNA and subsequent production of low amounts of Cftr protein
(10-20%) substantiated for the amelioration of the basic defect in the nose and the
intestine with the presentation of a subnormal phenotype when compared to wild type
and F508del homozygous animals. In order to dissect the role of the mutation from the
genetic background the CftrTgH(neoim)Hgu was backcrossed to three different inbred genetic
backgrounds (C57BL/6, BALB/c, DBA/2J). The demand of a high throughput
identification of animals carrying the insertional mutation led to the establishment of a
PCR based protocol whereby the Southern RFLP was replaced with intragenic Cftr
microsatellite markers directly linked with the disrupted locus in exon 10. This
alternative method assisted in the identification of unexpected events such as Cftr
intragenic recombination between the donor and the recipient allele and construct
excision. Microsatellite markers also provided a useful tool for the genetic
characterisation of the two inbred CF strains and the three inbred wild type strains
aiming to identify the genetic relationship of the strains before the phenotypic
characterisation of the congenic CftrTgH(neoim)Hgu animals allowing for future linkage
studies which will permit the mapping of modifiers of this cystic fibrosis phenotype.
Key Words: cystic fibrosis, mouse model, microsattelite genome scan.
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Abstrakt
Cystische Fibrose (CF) ist eine autosomal rezessive Vererbte und hinsichtlich des
Schweregrades der Pathologie stark variable Erkrankung, die durch Mutationen im
Cystic Fibrosis Transmembrane Conductance Regulator – Gen (CFTR) ausgelöst wird.
Das CFTR-Gen kodiert für einen durch Phosphorylierung regulierten Chloridkanal, der
in der Apikalmembran epithelialer Zellen exprimiert wird. Die Beschreibung des
murinen Homologs (Cftr) des menschlichen CFTR-Gens hat es ermöglicht, transgene
Mäuse als Tiermodell der CF zu entwickeln. Durch Insertionsmutagenese im Exon 10
des Cftr-Gens haben Dorin et al., 1992 das CftrTgH(neoim)Hgu Mausmodell der CF
entwickelt. Aus einem  Paar homozygoter CftrTgH(neoim)Hgu Tiere mit gemischtem
genetischen Hintergrund wurden die Inzuchtstämme CF/1- CftrTgH(neoim)Hgu und CF/3-
CftrTgH(neoim)Hgugezüchtet. Im Rahmen dieser Arbeit wurden diese beiden CF
Inzuchtstämme genetisch und phänotypisch charakterisiert. Biochemische und
funktionelle Analysen der beiden Inzuchtstämme haben gezeigt, daß diese
Inzuchtstämme ― im Gegensatz zu ihren Vorfahren mit gemischtem genetischen
Hintergrund ― Spuren  von regelgerecht prozessierter Cftr-mRNA bilden und
nachfolgend geringe Mengen von Cftr-Protein  (10-20%) exprimieren. Diese Menge des
Cftr-Proteins stellt die Basis für die bei den Tieren beobachtete Verbesserung des
Basisdefektes in nasalem und intestinalem Gewebe dar, wobei sich der Phänotyp der
Inzuchtstämme im Vergleich zu Wildtyp-Tieren und zu F508del homozygoten CF
Mäusen als subnormal darstellt. Um den relativen Einfluß der Mutation von dem des
genetischen Hintergrundes zu unterscheiden, wurden die CftrTgH(neoim)Hgu  Mäuse in drei
verschiedene Inzuchtstämme rückgekreuzt (C57BL/6, BALB/c, DBA/2J). Für diese
Kreuzungsexperimente mußte ein Hochdurchsatzverfahren entwickelt werden, das die
Identifikation der Tiere erlaubt, die die Insertionsmutation tragen. Zu diesem Zweck
wurde das bislang genutzte zeitaufwendige Verfahren der Southernblot-RFLP-
Typisierung durch die Typisierung mit intragenischer Mikrosatelliten, die im
Kopplungsungleichgewicht mit dem unterbrochenen Exon 10 liegen, substituiert. Diese
alternative Methode erlaubte es, unerwartete Ereignisse während der Zucht ― wie die
intragenische Rekombination zwischen Wildtyp-Allel und CF-Allel sowie die Exzision
des Insertionskonstruktes ―  zu erkennen und zu dokumentieren.
Mikrosatellitenmarker wurden desweiteren eingesetzt, um die beiden CF
Inzuchtstämme und die drei Wildtyp-Inzuchtstämme genetisch zu charakterisieren.
Diese Daten dienen als Grundlage für zukünftige Kopplungsanalysen, die die
Kartierung von Modulatoren des CF Phänotyps in den verschiedenen CF-Mäuselinien
Charakterisierung ermöglichen werden.
Schlagwörter: Cystische Fibrose, Mausmodell, Microsatelliten.
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Chapter 1
Mouse Models Of Cystic Fibrosis-General Introduction.
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1.1) Cystic Fibrosis
The autosomal recessive disease Cystic Fibrosis (CF) was first recognised as an entity by
Fanconi in 1936. Andersen gave the first detailed description of the disease and called it
“cystic fibrosis of the pancreas”. Farber (1945) introduced the term, “mucoviscidosis” which
became popular in North America, but “cystic fibrosis” became the term most frequently
used. The cloning, in 1989, of the gene responsible for the disease- the cystic fibrosis
transmembrane conductance regulator (CFTR) (Riordan et al., 1989, Rommens et al., 1989,
Kerem et al., 1989)- sparked understanding of the genetics of CF. Located on the long arm of
chromosome 7, it spans over 250kb, contains 27 exons and encodes a 1480 residue
transmembrane glycoprotein. The protein consists of two repeated motifs made up of six
membrane spanning segments, and a nucleotide binding domain (NBD) separated by a
regulatory domain (R domain) with multiple potential phosphorylation sites.
CFTR is being highly expressed in the epithelial cells of the sweat ducts, the pancreatic ducts,
the digestive tract, particularly in the crypts of the small intestine and Brunner’s glands, the
biliary ducts, the salivary glands, the reproductive organs and the lungs, particularly in the
serous cells of the submucosal glands and in the respiratory epithelial cells (Davis et al.,
1996). Characteristic manifestations of the CF disease are primarily due to the dysfunction of
exocrine glands resulting in the production of viscus dehydrated secretions. The resulting
phenotype is salty sweat, pancreatic insufficiency, intestinal obstruction with meconium ileus
(MI) in 10-20% few days after birth, infertility and severe pulmonary disease (Anderson et
al., 1992). CFTR functions as a cAMP- regulated chloride ion channel at the apical membrane
of epithelial cells, and the electrophysiological profile of affected tissues shows characteristic
abnormalities in the transport of chloride and sodium ions across the apical membrane.
Palmonary disease is the major cause of morbidity and mortality in CF, patients develop
chronic bacterial infection, abnormal airway secretions and airway inflammation, resulting in
progressive bronchiectasis, respiratory failure and death (Davidson et al., 1998).
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1.2) Generation of mouse models of cystic fibrosis
1.2.1) The murine CF gene.
The murine homologue of the human CFTR gene on chromosome 6 was isolated in 1991
(Tata et al., 1991 ). The Cftr gene spans 152kb, sequencing and comparative analysis with the
human CFTR gene (Ellsworth et al., 2000), revealed high similarity between the 27 exons
with the human homologue. Also on the protein level the murine CFTR protein displays a
78% overall sequence identity at the amino acid level with the majority of known CF
mutations occurring in conserved regions (Dorin et al., 1994a).
1.2.2) Mouse models
To date thirteen CF mouse models have been described in the literature. For the creation of
the CF mouse models the murine Cftr gene is mutated in the desired fashion and cloned into a
targeting vector which is then inserted into murine embryonic stem cells (Robertson et al.,
1986, Gossler et al., 1986, Doetschman et al., 1986). The mutated gene integrates into the
homologous gene locus of the stem cells via homologous recombination (Smithies et al.,
1985, Thomas et al., 1987). Correctly targeted stem cells are isolated, expanded, injected into
murine blastocysts, and transferred to a pseudo-pregnant foster mother. This produces a
chimeric mouse, which is a blend of both the normal cells and the cells containing the targeted
Cftr gene. With the use of this basic technique, mouse models have been generated which
have been designed to disrupt the Cftr gene, either by using a replacement gene-targeting
strategy resulting in the creation of animals with no normal Cftr production (Cftr tm1Unc,
Cftrtm1Cam, Cftrtm1Hsc, Cftrtm3Bay) (Snouwaert et al., 1992, Ratcliff et al., 1993, Rozmahel et al.,
1996, Hasty et al., 1995), or using insertion into the target gene with no loss of genomic
material (CftrTgH(neoim)Hgu, Cftrtm1Bay) (Dorin et al., 1992, O´Neal et al., 1993).  Mouse models
designed to reproduce known clinical mutations have been created using either replacement
gene targeting (Cftrtm2Cam, Cftrtm1Kth, Cftrtm1G551D) (Colledge et al., 1995, Delaney et al., 1996,
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Zeicher et al., 1995)or double homologous recombination procedure (‘hit and run’)
(Cftrtm2Hgu, Cftrtm1Eur) ((Dickinson et al., 2002, van Doorninck et al., 1995).
1.3) Phenotypes of mouse models of CF
The phenotype among the CF mouse models is fairly similar with variations which relate to
the specific mutation generated, to environmental influences and to independently segregating
modifier genes.
1.3.1) Survival of mouse models
The survival rates of the different mouse models vary from <5% in the Cftrtm1Unc (Snouwaert
et al., 1992), Cftrtm1Cam (Ratcliff et al., 1993) Cftrtm1Hsc (Rozmahel et al., 1996) with no wild
type Cftr mRNA detectable and the Cftrtm2Cam (Colledge et al., 1995) with 15% of normal
expression levels of mutant Cftr mRNA, to 90% survival in the CftrTgH(neoim)Hgu (Dorin et al.,
1992), which has shown to have 10% of normal levels of wild type Cftr mRNA to normal
survival as seen in the Cftrtm2Hgu (Dickinson et al., 2002) and Cftrtm1Eur (van Doorninck et al.,
1995) mouse models with mutant Cftr mRNA expression at normal levels. The most
predominant cause of mortality of the CF mouse models is the severity of intestinal
pathology, which appears to be the hallmark of the induced mutations in the murine Cftr gene.
However, these differences in the rates of survival reflect that severity of intestinal pathology
vary as a result of certain mutation specific effects such as residual activity of wild type Cftr
mRNA. The low level 10% of wild type Cftr has been proposed to be the explanation for the
significantly greater survival rate in the CftrTgH(neoim)Hgu mouse model (Dorin et al., 1994b).
Because of the targeting strategy used in its generation, exon skipping and aberrant splicing
produce normal Cftr mRNA (Kent et al., 1996), resulting in a much milder gastrointestinal
phenotype than exhibited by the other knockout mouse models. Other factors that have been
shown to influence the survival rate of the various mouse models is the environment in
particular the diet and the housing conditions. The lifespan of the Cftrtm1Unc mouse model has
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been prolonged when solid diet was replaced with liquid diet (Kent et al., 1996). Delaney et
al., (1996) have shown that survival of the Cftrtm1G551D mouse model was influenced by the
sterility of the housing conditions. Transfer of the Cftrtm1G551D mice from a specific pathogen-
free (SPF) environment to a standard animal facility resulted in increased mortality.
1.3.2) Intestinal disease
In the human subject, the intestinal manifestation of CF in the small intestine is characterized
by decreased Cl- and fluid secretion, which may contribute to the meconium ileus (MI) in
approximately 10% of CF newborns and intestinal obstruction and accumulation of mucus in
older CF patients (Eggermont et al., 1991). The intestinal phenotype appears to be the
hallmark of all CF mouse models. With the exception of two of these models, Cftrtm2Hgu
(Dickinson et al., 2002) and Cftrtm1Eur (van Doorninck et al., 1995), the intestinal pathology is
severe. Mucus accumulation in the crypts of Lieberkuhn, goblet cell hypertrophy (Cftrtm1Unc)
(Eckman et al., 1995), hyperplasia (Cftrtm1Unc) (Eckman et al., 1995), Cftrtm1Hsc (Rozmahel et
al., 1996) and Cftrtm1Bay (O´Neal et al., 1993), and eosinophilic secretions in the crypts
(Cftrtm1G551D, Cftrtm3Bay , Cftrtm1Bay  , Cftrtm1Eur ) (Delaney et al., 1996, Hasty et al., 1993,
O´Neal et al., 1993, van Doorninck et al., 1995) are some of the intestinal pathology features
observed in CF mouse models.
Intestinal mortality and morbidity in CF mice manifests during two time periods before
weaning and after. A large fraction of CF mice die shortly after birth from severe intestinal
complications (Cftrtm1Kth, Cftrtm1Bay, Cftrtm1Hsc), whereas others die shortly after the weaning
period (Cftrtm1Unc, Cftrtm1Cam). Consumption of solid food has been postulated to be the
causative reason for the post weaning high rate of mortality in CF mice, it has been shown
that liquid diet prolongs the lifespan of these animals (Eckman et al., 1995, Kent et al.,1996).
Furthermore Grubb et al., (1995) found that substitution of the drinking water with an
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electrolyte solution containing 6% polyethylene glycol (Colyte), greatly prolonged the life
span of the Cftrtm1Unc mouse model.
With respect to intestinal physiology, all of the CF mouse models have a very similar
physiological phenotype to that of the human intestine which corresponds to defective cAMP-
mediated Cl- conductance. Studies characterising the electrophysiological profile of the
intestine in CF mouse models revealed great similarity between the intestinal phenotype of the
various mouse models. CF mouse models display a significant decrease (Cftrtm1G551D,
CftrTgH(neoim)Hgu , Cftrtm1Eur) ( Delaney et al., 1996, Smith et al., 1995, van Doorninck et al.,
1995) or complete absence of cAMP-mediated Cl- secretion across the intestinal epithelium
(Clarke et al., 1992, Colledge et al., 1996, Hasty et al., 1995, Ratcliff et al., 1993., Zeicher et
al., 1995). In the Cftrtm1Unc mouse model, all intestinal regions from the duodenum to the
distal colon exhibited defective cAMP-regulated Cl- ion transport (Grubb et al., 1997). In the
CftrTgH(neoim)Hgu mouse the residual function nature of the insertional mutation has been
postulated to be the cause of the observed mild instestinal disease phenotype in these mice
(Dorin et al., 1994b).
In contrast to the two F508del mouse models Cftrtm1Kthand Cftrtm2Cam the Cftrtm1Eur F508 del
mouse model does not exhibit increased mortality due to intestinal complications and shows a
substantial Cl- secretory response to an increase in cAMP  (van Doorninck et al., 1995).
Cftrtm1Kth and Cftrtm2Cam exhibit a reduction in mRNA levels for the mutated Cftr (Zeicher et
al., 1995, Colledge et al., 1996) whereas the Cftrtm1Eur mouse model expresses mRNA levels
for the mutated CFTR comparable to the levels of the wild type control littermates (French et
al., 1996). It has been speculated that this high level of mRNA may allow more of the mutant
CFTR to be correctly processed allowing more functional protein to reach the plasma
membrane.
With respect to Ca2+ activated Cl- secretory responses the intestine of the CF mouse models is
similar to that of its human homolog, Like the normal human intestine normal murine
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intestine reacts to agonists that increase intracellular Ca2+ with a Cl- secretory response,
whereas human CF patients and mice lacking functional CFTR as the Cftrtm1Unc/Cftrtm1Unc ,
Cftrtm3Bay/Cftrtm3Bay (Hasty et al., 1993, Grubb et al., 1997, Cuthbert et al., 1994, Clarke et al.,
1994) CF mouse models exhibit no Cl- secretory response to these agents.
1.3.3) Lung disease
The major cause of morbidity and mortality in CF humans is due to pulmonary manifestations
of the disease, therefore, the airways of the CF mouse models is of major interest. Unlike the
reports of severe gastrointestinal pathology in the CF models there is an observed lack of
pulmonary pathology.
For the Cftrtm1G551D, Cftrtm1Unc, Cftrtm1Kth  CF mouse models the findings with respect to
airway hyperabsorption of Na+ across the nasal mucosa is consistent with what is seen in CF
patients as indicated by a significantly enhanced baseline nasal PD in vivo (Delaney et al.,
1996, Grubb et al., 1994, Wilschanski et al., 1996, Zeicher et al.,  1995). Decreased or even
absent cAMP-stimulated Cl- conductance was observed in all of the CF mouse models tested
with the exception of the Cftrtm1Eur (van Doorninck et al., 1995) and the CftrTgH(neoim)Hgu
(Smith et al., 1995) models. The approximate 10% of wild type Cftr mRNA in the lung of the
CftrTgH(neoim)Hgu mouse model and the normal levels of F508del Cftr in the Cftrtm1Eur mouse
could explain, according to the authors, the response to the low Cl- perfusion (van Doorninck
et al.,1995, Smith et al., 1995). In the human airway tissue, stimulated Cl- secretion is
mediated almost equally by the Cftr channel and a molecularly distinct, alternative Ca2+
regulated channel in the apical membrane (Boucher et al., 1989). The nasal mucosa of
Cftrtm1Unc and Cftrtm1Hsc mice have been reported (Grubb et al., 1994, Wilschanski et al., 1996)
to display a raised Ca2+- mediated Cl- secretory pathway which could partially alleviate the
effects of Cftr dysfunction in these mouse models.
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The physiology of the murine distal airways (trachea, bronchi) appears to be different from
that of the upper airways (nasal mucosa). Reports from studies on the tracheas of CF mouse
models such as the Cftrtm1UNC  (Grubb 1994a), CftrtmG551D ( Delaney et al., 1996) Cftrtm2Cam (
Colledge  et al., 1995)  mice reported no difference in the amiloride-sensitive Isc of the CF
tracheas when compared with that of the normal trachea. A reduction in the amiloride-
sensitive Isc in the CF murine trachea when compared with the normal was also reported for
the Cftrtm1Cam (Hyde et al., 1993) and CftrTgH(neoim)Hgu (Smith et al., 1995) mouse models, the
authors suggested that in contrast to humans the loss of Cftr does not result in the
upregulation of the epithelial Na+ channel in the murine trachea. Zeicher et al., (1995)
reported the presence of little or absent Cftr expression in the tracheas of normal mice and the
existence of an alternative non-Cftr Cl- channel has been proposed. Studies on the Cftrtm2Cam
(Colledge et al., 1995) showed that in CF animals between the age of 18-32 days the forskolin
response was present but significantly reduced from that in the normal trachea. A similar
pattern was detected in the trachea of the CftrtmG551D mouse model (Delaney et al., 1996). In
the two knockout CF models (Cftrtm1UNC, Cftrtm1Cam) the cAMP mediated Cl- secretory
response was found to be identical with that of the normal trachea. Cftr mediated Cl- secretion
could not be supported in these animals due to lack of functional Cftr supporting the
hypothesis that an alternative Cl- secretory pathway. A study using the Cftrtm1UNC mouse
model (Grubb 1994a) revealed that the cAMP- mediated Cl- response in the murine CF
trachea is via an intracellular Ca2+- mediated non-Cftr pathway.
1.3.4) Lung pathology
CF airways are particularly susceptible to chronic bacterial infection and intense inflammation
that results in significant tissue damage and eventual failure of lung function. Common
bacterial pathogens that infect the CF lung include Staphylococcus aureus, Haemophilus
influenzae and Pseudomonas aeruginosa (PA). PA persists in the airways forming, forming
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microcolonies embedded in a mucoid exopolysaccharide called alginate (Pilewski et al.,
1999). Initial studies using the outbred MF1/129- CftrTgH(neoim)Hgu   mouse model no gross lung
disease was observed at birth or in those animals born and raised in isolator conditions
(Davidson et al., 1995). Evaluation of the cytokine levels in bronchoalveolar lavage fluid
(BALF) from untreated MF1/129 CftrTgH(neoim)Hgu  mice revealed significantly increased levels
o the pro-inflammatory cytokine tumour necrosis factor a (TNF-α) in the mutant mice in
comparison with non-CF controls (Morrison et al., 1997).
One indicator of the chronic inflammatory status of CF patients is the presence in the serum
of two S-100 calcium- binding proteins, S100A8 and S100A9 (Barthe et al., 1991). S100A8
was identified independently in mouse as a powerful proinflammatory chemotactic factor
(Lackmann et al., 1992) while both S100 proteins also exhibit antimicrobial activity. The
expression of S100A8 mRNA in murine macrophages is inducible by bacterial LPS (Hu et al.,
1996).  Thomas et al., (2000) using the Cftrtm1G551D CF mouse model demonstrated that
intravenous injections of lipopolysaccharide (LPS) into these mutant mice induced S100A8
mRNA in the lung to a greater extent than in wild type litermates. Bone marrow-derived
machrophages from the same mice were shown to also exhibit hypersensitivity to LPS,
measured by induction of TNF-α, providing evidence that the pathology of CF relates to
abnormal regulation of the immune system.  McMorran et al., (2001) using again Cftrtm1G551D
mice examined the response of the animals during the early acute phase of infection with PA,
between 1 and 3 days after bead inoculation. Concentration of TNF-α was significantly higher
than in non-CF littermates 24h after infection, followed by a rapid loss of weight. 48h after
infection a decline of inflammatory cytokines was observed, the authors speculated that this
decline could predict the ineffective bacterial clearance. In studies using the MF1/129/-
CftrTgH(neoim)Hgu  mouse model an impaired airway clearance of aerosolised Staphylococcus
aureus and Burkholderia cepacia, in comparison with non-CF animals was demonstrated
(Davidson et al., 1995). Repeated exposure to these bacteria resulted in formation of
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lymphocytic aggregates, mucus retention, bronchiolitis, pneumonia and oedema. The same
results were obtained from CftrTgH(neoim)Hgu  mice bred to the inbred C57BL/6 genetic
background (Cowley et al., 1997). Coleman et al., (2003) demonstrated that under the proper
conditions, transgenic Cftrtm1Unc mice are hypersusceptible to P.aeruginosa colonisation and
infection. When the bacterium was present in drinking water, heterozygous and homozygous
CF mice housed in the same cage became chronically colonized in the oropharynx with
environmental PA. Elimination of PA from drinking water resulted in clearance in most wild
type and CF heterozygous but not homozygous mice.
1.3.5) Pancreatic disease
In human CF patients, pancreatic insufficiency is a prominent manifestation of CFTR
dysfunction. The acinar epithelia secrete digestive enzymes, and the CFTR-expressing ductal
epithelia secrete a HCO3-rich liquid that flushes the enzymes into the duodenum. In the
human CF patient mucins plug the pancreatic ducts leading to inspissated luminal proteins.
Digestive enzymes which are secreted by the acinar epithelia accumulate in the acini due to
the blocked ducts, leading to enlarged acini, autolysis and their replacement with fibrotic
tissue . In contrast to what is seen in the human CF patient, pancreatic disease is less severe in
the CF mouse models. Studies on the F508del and G551D CF mouse models did not report
any severe pancreatic pathology (Colledge et al., 1996, Delaney et al., 1996, van Doorninck
et al., 1995, Zeicher et al., 1995). A more variable pancreatic pathology has been reported for
the knockout CF mouse models. Studies using the Cftrtm1Cam mouse model reported blockage
of some of the pancreatic ducts in approximately 50% of the mice examined, but the
pancreatic function was not altered (Ratcliff et al., 1993). Cftrtm1Bay and Cftrtm3Bay exhibited
acinar atrophy which progressed as the mice aged (O´Neal et al., 1993, Hasty et al., 1995). In
the Cftrtm1Unc knockout mouse model, two of five mice examined exhibited enlarged acini
containing eosinophilic material in one or two lobes of the pancreas (Snouwaert et al., 1992).
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The CftrTgH(neoim)Hgu mouse model exhibits no pancreatic pathology probably due residual
amounts of wild-type CFTR (Gray et al., 1994).
Electrophysiological experiments using normal pancreatic ductal cells with Ussing chambers
(Clarke et al., 1994) and whole cell patch clamp (Gray et al., 1994, Winpenny et al., 1995)
suggested the existence of an alternative fluid secretory pathway which is activated by
increases in intracellular calcium ions (Ca2+) consistent with a previous study (Snouwaert et
al., 1992) which reported low level of Cftr expression in the murine pancreas.
1.3.6) Reproductive tissue
Most male human CF patients are infertile because of atresia or obstraction of the vas
deferens and distal epididymis (Heaton et al., 1990). Snouwaert et al., (1992) reported high
levels of Cftr mRNA expression in the testes and epididymis of the Cftrtm1Unc mouse model,
and no pathology of the male reproductive tract has been reported for any of the CF mouse
models characterised in literature. It was found that normal tissue exhibited a cAMP-mediated
(forskolin) Cl- secretory response, which was lacking in the CF testes (Leung et al., 1996). A
larger Cl- response was elicited by agents that raise intracellular Ca2+ such as ionomysin and
ATP and this Ca2+ mediated Cl- secretion was found to persist to the same level in the male
reproductive tissue from the CF mice. It was speculated by the same author that fertility in the
male CF mouse is maintained by the presence of the predominant Ca2+ mediated Cl- secretory
pathway in the epididymides and seminal vesicles. Female CftrTgH(neoim)Hgu and Cftrtm1Kth mice
are fertile, whereas Cftrtm1Cam and CftrG551D homozygous mice are mostly infertile. In a study
(Leung et al., 1996) on primary cultures of murine oviductal epithelium from normal and
Cftrtm1Unc mice it was reported that like in the male reproductive tissue, ATP-stimulated Ca2+
–mediated Cl- secretory response was significantly higher than the cAMP-mediated Cl-
secretory response which was maintained also in the CF mouse.
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1.4) Phenotype Modification
1.4.1) Genetic Background
One of the advantages when working with mice is the availability of inbred strains, according
to the committee on Standardised Genetic Nomenclature for mice (1952) a strain is
considered to be inbred after at least 20 consecutive generations of brother x sister mating,
which can be traced to a single ancestral breeding pair. An inbred strain is genetically uniform
(isogenic) and utilisation of these strains in research helps to eliminate the genetic variation.
Along with the environmental conditions such as diet or housing conditions another factor
actively influencing the severity of the phenotype and hence the different survival rates of the
various CF mouse models is the background strain. However, generation of the various CF
mouse models did not put emphasis upon the choice of the background strain used, and initial
characterisation of these mouse models did not take into account the role that the background
strain may have upon the phenotype. The severity of lung disease in CF mice kept alive on a
liquid diet has been shown to be influenced by genetic background (Kent et al., 1997). In
order to dissect the role of the mutation from the genetic background the CF mouse models
are backcrossed with chosen inbred strains and the resultant offspring is congenic with 99.9%
inbred background after ten backcrosses. Establishment of congenic CF mutant animals
results in the generation of CF mouse models which differ only in the nature of the mutation
in Cftr. In their study Kent et al., (1997) demonstrated that intergrossing of the Cftrtm1Unc
mutation the inbred C57BL/6J genetic background (congenic) resulted in lung disease in the
absence of detectable infection absent in Cftrtm1Unc CF animals of a mixed genetic background.
1.4.2) Modifier loci
Mouse models present powerful means to identify secondary genetic modifiers (Nadeau
2001). Establishment of different inbred strains with the same Cftr mutation (congenic),
allowed the comparison between various inbred strains facilitating the search of
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independently segregating modifier loci. Rozmahel et al., (1996), mapped a modifier gene
locus on chromosome 7 (Cfm1). On the basis of the human-mouse homology map, Zielenski
et al., (1999) demonstrated the existence of a genetic locus (CMF1), presumably equivalent to
Cmf1,  that could determine the susceptibility to meconium ileus in CF patients.
Haston  et al., (2002a), using quantitative trait loci (QTL) mapping on the F2 (B6xBALB/c)
of congenic strains in which the Cftrtm1Unc mutation (Snouwaert et al., 1992) was crossed with
C57BL/6J and BALB/c inbred mice, identified  putative CF body weight modifiers on
chromosomes 13, 7 and 10. Significant linkage of the fibrotic lung phenotype was also
detected (Haston et al., 2002b) for a region on Chromosome 6.
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Scope of this thesis
 Background The ability to selectively alter the mouse genome has given a great boost
to the research of cystic fibrosis (CF) with the generation of mouse models of CF. The
availability of inbred i.e. isogenic mouse strains along with the ongoing progress on
the mouse genome provided scientists with a useful tool whereby the complexity of
inherited genetic disorders such as cystic fibrosis can be analysed. Moreover, the
ability to introduce the mutation on to a different inbred genetic background
generating congenic animals facilitated the search for modulators of CF. At present
there are several mouse models of CF described in the literature with variable degrees
of characterisation, in the context of this thesis the two inbred CF strains CF/1-
CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu are being genetically and phenotypically
characterised.
Generation of CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu.  Dorin et al., 1992
described the generation of a mouse model of CF using insertional mutagenesis to
disrupt the murine Cftr gene in exon 10. For the establishment of the inbred population
a pair of mixed genetic background was obtained from the MRC Human Genetics
Unit, Edinburgh. Two separate litters were obtained and two animals of each litter
became the starting population for the establishment of the two individual inbred
CftrTgH(neoim)Hgu  lines CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu which were
generated by brother x sister mating for now more than 26 generations.
 Objectives of the study The study as described in this thesis has three major aspects:
the phenotypic characterisation of the two inbred CF strains CF/1- CftrTgH(neoim)Hgu and
CF/3- CftrTgH(neoim)Hgu; their genetic characterisation by using microsatellite markers;
and the estimation of their genetic relationship with the three wild type inbred strains
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BALB/c, C57BL/6J and DBA/2J, which were used for the generation of congenic
CftrTgH(neoim)Hgu animals.
Chapter 2 describes the use of an alternative PCR based protocol whereby identification
of the insertional mutation in the recipient inbred strains (during generation of congenic
animals) was established using Cftr intragenic microsatellite markers linked with the
disrupted locus (Cftr exon 10). The feasibility of this type of characterisation is discussed
along with the finding of vector excision revealing the instability of the construct used to
generate the mutant animals.
Chapter 3 deals with the phenotypic characterisation of the two inbred CF strains CF1-
CftrTgH(neoim)Hgu and CF3- CftrTgH(neoim)Hgu. This characterisation comprised of mRNA analysis
along with Cftr protein detection using western blot with the R3195 CFTR antibody in the
intestine followed by immunocytochemical analysis both in the nose and the intestine. The
electrophysiological defect of cystic fibrosis in the two inbred CF strains CF/1-
CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu was assessed using short circuit measurements
(SCC) both in the nose and the intestine and was compared along with wild type control
animals and F508del homozygous Cftrtm1Eur mutants.
Chapter 4 describes the genetic characterisation of the two inbred CF strains CF/1-
CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu and the three inbred wild type strains C57BL/6J,
DBA/2J and BALB/c by using microsatellite markers. The aim of this study was to identify
the strain distribution patern between the two CF strains and the three inbred strains before
analysing the introgressed CftrTgH(neoim)Hgu mutation in the three inbred backgrounds.
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Chapter 2
Instability of the insertional mutation in CftrTgH(neoim)Hgu cystic
fibrosis mouse model
31
Abstract
Two inbred CftrTgH(neoim)Hgu mouse lines CF/1 and CF/3 were generated from the original
CftrTgH(neoim)Hgu cystic fibrosis mouse model by brother x sister mating. Thereafter the
insertional mutation was introgressed from CF/3 into three inbred backgrounds
(C57BL/6, BALB/c, DBA/2J). Transmission of the insertional mutation during
backcrossing was monitored by direct probing the insertion via Southern RFLP and
indirectly by informative marker haplotype using intragenic Cftr microsatellites. This
method facilitated the identification of unexpected events such as recombination in the
Cftr gene during congenic breeding between the wild type and the mutant allele as well
as precise vector excision from the disrupted Cftr locus. This reversion to wild type
status took place without any loss of sequence revealing the instability of insertional
mutations during the production of congenic animals.
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2.1) Introduction
Cystic fibrosis (CF) is a common and fatal recessive disease, which is caused by dysfunction
of a chloride channel, termed the CF transmembrane conductance regulator (CFTR). Since the
isolation of the murine homologue of the human CFTR gene on Chromosome 6 (Tata et al.,
1991) several mouse models have been created. These fall broadly into two different
categories; those designed to mimic clinical human mutations such as the F508del ( Colledge
et al., 1995; van Doorninck et al., 1995; Zeiher et al., 1995), G551D (Delany et al., 1996) and
G480C ( Dickinson et al., 2002), and those with a disrupted Cftr gene resulting in either no or
reduced production of CFTR. Although most mouse models share phenotypic characteristics,
particularly, the most CF-like severe pathology is observed in the gastrointestinal tract,
important variations in phenotype have been observed which may relate to the specific
mutation and the genetic background of the targeted strain.  Studies using Cftr knockout mice
demonstrated differential severity of airway (Kent et al., 1997) and intestinal (Rozmahel et
al., 1996) disease. Candidate modulators for growth, airway and intestinal disease have been
mapped to loci on chromosomes 1, 6, 7, 10 and 13 (Haston et al., 2002a) ; 1, 2, 10 and 17
(Haston et al., 2002b); 3 and 5 (Haston et al., 2002c),  respectively.
Dorin et al. (1992) established a CF mutant mouse CftrTgH(neoim)Hgu, using an insertional gene
targeting vector to disrupt exon 10 of the Cftr gene in 129P2 embryonic stem cells. This
targeted mutation was made by insertional mutagenesis using a fragment of DNA containing
intron 9 and part of exon 10 (Figure 1). The mutation is slightly “leaky”, in that low levels of
wild type Cftr mRNA are produced as a result of exon skipping and aberrant splicing (Dorin
et al. 1994), but these mutant mice nevertheless displayed the electrophysiological defect in
the gastrointestinal and respiratory tract which is characteristic of CF (Smith et al. 1995).  We
have generated two different inbred lines named CF/1- CftrTgH(neoim)Hgu  and CF/3-
CftrTgH(neoim)Hgu using brother-sister mating for more that 26 generations. In order to test
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whether the genetic background of the CftrTgH(neoim)Hgu mouse influences the development of
the phenotype, we introgressed the mutation from the CF/3- CftrTgH(neoim)Hgu  into three
different inbred strains (C57BL/6, BALB/c, DBA/2J) generating B6.129P2(CF/3)-
CftrTgH(neoim)Hgu, C.129P2(CF/3)- CftrTgH(neoim)Hgu, D2.129P2(CF/3)- CftrTgH(neoim)Hgu  congenic
mice. During backcrossing the targeted mutation was determined by Southern RFLP analysis
of XbaI/SalI genomic digests with probe 1.2H (Figure 1) as outlined in the original report
(Dorin et al., 1992). Here we describe an alternative genotyping technique utilising
informative Cftr intragenic microsatellite markers in order to follow germline transmission of
the mutated Cftr locus in the three inbred backgrounds. The four markers spanning 101kb of
the Cftr gene allowed straight forward differentiation between the two inbred CF lines and the
three inbred wild type strains by microsatellite haplotype. Southern and microsatellite
mutation genotypes were confirmed in 55 of 57 typed mice two of which harboured a
recombination in the Cftr gene. In two cases, however, the insertion mutation status deduced
from Southern hybridisation and microsatellite genotypes did not match. Further mapping and
sequencing revealed that the 7.3kb insertion vector had been excised from the Cftr locus. This
spontaneous reversion to wild type sheds serious doubts for the stability of insertion
mutations in heterozygous mice.
Figure 1. a) Insertional disruption of the murine Cftr gene and predicted
by Dorin et al., (1992). Abbreviations: S, SalI; H, HindIII; X, Xba
heterozygous cf/+ matings. The probe 1.2H isused in order to identify vi
congenic mice which carry the insertion. DNAs were digested with XbaI
The upper hybridising fragment of 6.6Kb represents the wild type allele
diagnostic for the insertional mutation
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2.2) Materials and Methods
2.2.1) Experimental animals.
All experiments were approved by the local Institutional Animal Care and Research Advisory
Committee as well as by the local government. CftrTgH(neoim)Hgu mice were bred under
specified pathogen-free conditions in the isolator unit of the Central Laboratory Animal
Facility of the Hannover Medical School. Mice were kept in a flexible film isolator. The
temperature within the isolator was maintained at 20-24ºC with 40-50% relative humidity.
Animals were fed an irradiated (50 kGy) standard chow (Altromin 1314) and autoclaved
water (134ºC for 50min) ad libitum.
2.2.2) Generation of inbred CftrTgH(neoim)Hgu mutant mice.
For the establishment of the inbred CF/1- CftrTgH(neoim)Hgu   and CF/3- CftrTgH(neoim)Hgu
population, one pair with divergent genetic background (generation F4) of one homozygous
male and one homozygous female was obtained from the MRC Human Genetics Unit,
Edinburgh. Two separate litters were obtained and two animals of each litter became the
starting population for the establishment of the two individual inbred CftrTgH(neoim)Hgu  lines
CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu which were generated by brother-sister
mating for now more than 26 generations.
2.2.3) Generation of congenic CftrTgH(neoim)Hgu mutant mice.
CF/3- CftrTgH(neoim)Hgu mice served as donors for the development of the three congenic strains
C57BL/6, BALB/c and DBA/2J, with selection for CftrTgH(neoim)Hgu for 10 generations.
Genotyping of the insertion mutation was conducted by Southern analysis of XbaI/SalI
restricted genomic DNA from spleen (Dorin et al., 1992).
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2.2.4) DNA purification.
High molecular weight DNA was isolated from 0.15g spleen tissue, either fresh or thawed on
ice after storage at -20ºC based on the protocol by Gross-Bellard et al., (1973).
2.2.5) Southern blot genotyping.
Heterozygous and homozygous CftrTgH(neoim)Hgu  animals were identified in each backcross
generation via Southern Blot Hybridization of XbaI/SalI genomic digests, using the 1.2H
probe located in the Cftr intron 10, after double digestion with XbaI-SalI (Figure 1). There are
no SalI sites in this region of the Cftr gene, but the targeting vector pIV3.5H carries a unique
SalI site immediately 3´ to the neo gene. Animals carrying the mutation were identified by the
novel 5kb XbaI-SalI fragment hybridizing to 1.2H.
2.2.6) Microsatellite selection.
The sequence available in the Genome Database (AF162137) was used for manual selection
of dinucleotide repeat units spanning the murine Cftr gene. Five microsatellite markers were
identified in Cftr intron 1 (D6NC3), intron 2 (D6NC4), intron 8 (D6NC2), intron 10 (D6NC1)
and intron 18 (D6NC5). Flanking primers designed with the oligonucleotide designing
program Primer 3 (www-genome.wi.mit.edu/cgi-bin/primer3.cgi/primer3_www.cgi) are listed
in Table 1.
Primer name Primer sequence 5´-3´
D6NC1-A BIOTIN-TGC TTG AGC TAT CCA TTC TGA
D6NC1-B TAC CCA ATG TTG CCA TCT GA
D6NC2-A BIOTIN-TTG GAA GTG AGG ATT GCC TT
D6NC2-B TGC CTC AGT CTC ATA TTA TTG C
D6NC3-A BIOTIN-TCT CAG CCT GTC TTC CTC TCA
D6NC3-B TCC TCC CAA AAC AGC TTC AC
D6NC4-A BIOTIN-GAG TTG GAG AGG CTG TTT GG
D6NC4-B TGT GCC AGG ACA CTG TGA CT
D6NC5-A BIOTIN-TTC AAA TGA CCA AAA TCC CC
D6NC5-B TGG CAA ATT TTC AAC AAC AAA
Table 1. Primer sequences used for the amplification of the intragenic Cftr microsatellites. The
forward primer is 5´biotinylated.
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2.2.7) Genotyping of microsatellites.
Microsatellite markers were genotyped in 96 well plates purchased from Greiner,
Frickenhausen, pre-coated with 50ng DNA per well in a Hybaid Thermocycler (Hybaid,
Teddington) with a heated lid. One of the two primers per microsatellite was 5´-terminal
biotinylated. PCR was performed in a total volume of 30µl, without oil overlay, using
InViTaq polymerase (InViTek, Berlin). After PCR an 8µl aliquot was transferred to a
multiwell plate and allowed to dry overnight at 37ºC, dissolved in 10µl loading buffer (0.2%
w/v xylenecyanol and bromphenolblue in formamide) and denatured for 5min at 95ºC. The
PCR products were separated by direct blotting electrophoresis (GATC 1500, MWG Biotech,
Ebersberg, Germany) on a denaturing acrylamide gel (4% acrylamide/N,N’-
methylenebisacrylamide 29:1 containing 6M urea in 0.9M Tris-0.9M boric acid-0.02M EDTA
buffer) and simultaneously transferred to a Hybond N+membrane (Amersham). Signals were
visualised by blocking the membrane in 1.5%(w/v) of blocking reagent in Buffer 1 ( 100mM
Tris-HCl, 150mM NaCl, pH 7.5), followed by incubation in diluted solution of anti-biotin
alkaline phosphatase conjugate in Buffer 1. The membrane was further washed three times
with 1% Triton X-100 in Buffer 1 and equilibrated for 15min in assay buffer (100mM Tris-
HCl, 100mM NaCl, 50mM MgCl2, pH 9.5). The membrane was covered for 5min with
reaction buffer containing 10%(v/v) Sapphire II (Tropix) and 60µl CDPstar (Tropix)in 50ml
assay buffer, followed by rinsing with a solution containing 1% v/v Sapphire II and 6µl
CDPstar in 50ml assay buffer. Signals were exposed to Kodak XA-R films and the exposition
time varied from 10min to 45min. Evaluation of results was performed as described by Mekus
et al., (1995).
2.2.8) Long-range PCR.
150ng of DNA template was each amplified in 12 different premixes using the Failsafe ™
PCR System ( EPICENTRE Technologies, WI USA). PCR products were amplified using
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primer described in Table 2 separated by 1% agarose gel electrophoresis and visualised under
UV illumination, the optimal reaction mixture was thereafter chosen for further
amplifications.
Primer name Primer sequence 5´-3´ Expected size Allele
Cftr-5012 CCT TCC ATG TAC CCC TCC TCA CTTCCC GGC ATA ATC CAA GAA AAT TG 5012bp Wild type
Cftr-5198 TGT GGG AAA TCC TGT GCT GAA ACTT CCG GCT CGT ATG TTG TGT T 5198bp mutant
Cftr-3736 CAC ACA ACA TAC GAG  CCG GAA GTTT ATT GCC GAT CCC CTC AGA A 3736bp mutant
Cftr-3473 CTC GTG CTT TAC GGT ATC GCCTGC TGT AGT TGG CAA GCT TTG A 3473bp mutant
         Table 2. Primer sequences used for the amplification of the long range products.
2.2.9) Neo PCR.
Cftr intron 9-pIV3.5H vector and neo -Cftr intron 9 spanning primers, (Table 3) were
amplified using PCR of 50ng DNA template in a total volume of 30µl with InViTaq
polymerase (InViTek, Berlin) in 96 well plates. Full-length and SalI restricted PCR products
were separated by 2.5% agarose gel electrophoresis.
Primer name Primer sequence 5´-3´ Expected size
CFneo 1-A CGT TGG CTA CCC GTG ATA TT 332bp
CFneo 1-B CTT CCA CAA GGC TTC CTG AG
CFneo2-A CCT GAT GTT GAT TTT GGG AGA 253bp
CFneo2-B ATT AAT GCA GCT GGC ACG AC
Table 3.  Primer sequences used for the amplification of the Cftr intron 9-pMC1 vector plasmid
sequence (CFneo2) and the neomysin- Cftr intron 9 (CFneo1) products.
2.2.10)Excision scanning by primer walking.
 Based on the Genome Database Cftr sequence (AF162137) 15 overlapping pairs (Table 4) of
primers spanning the entire region from exon 9 to intron 10 of the murine Cftr gene were
designed, using the Primer 3 oligo design program (www-genome.wi.mit.edu/cgi-
bin/primer3.cgi/primer3_www.cgi). PCR reactions were performed on DNA with inconsistent
Southern and microsatellite insertional mutation genotypes and controls in 96 well plates
precoated with 50ng of DNA template using InViTaq polymerase (InViTek, Berlin). Full
length products were separated on 2.5% agarose gels and visualised under UV illumination.
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Primer name Location Sequence 5´-3´ ProductSize
NCEx9I9-A 197720- 197742 TTT GGG GAA TTA CTG GAG AAA G 419bp
NCEx9I9-B 198138- 198117 AGC TCG CTG ATA GGT TAT CCA
NC10-A 198002-198023 CCC CTC CTC ACT TCC ATT AAA 400bp
NC10-B 198402-198381 TTT AAG GCT CAG GGC TAA TTG
NC11-A 198376- 198396 TTC CAC AAT TAG CCC TGA GC 649bp
NC11-B 199024- 199001 TGA AGG AAA TCA TTA CTG AAG CA
NC12-A 199001- 199024 TGC TTC AGT AAT GAT TTC CTT CA 550bp
NC12-B 199551- 199531 TAT GGA TCC CCA CAG CAA GT
NC13-A 199394- 199414 CTC AGG GAT TGT CAC GGT TT 563bp
NC13-B 199966- 199946 GCT TTG ATC TCT GGG AGC AC
NC14-A 199741- 199763 GAT CAC AGG AGC CTA GCA TAG A 550bp
NC14-B 200290- 200268 TTC ACT TTA CAT CCT GGC TTC A
NC15-A 200122- 200142 ACT GGG AGA GGA TGC AAA AA 575bp
NC15-B 200696- 200676 CCC AGT GTG AGA AGA TGC AC
NC16-A 200572- 200592 TGC TCC CAG AAA TCT TCA CC 582bp
NC16-B 201153- 201133 AGT TGT CAG AAG GGA ACC CA
NC17-A 201134- 201154 TGG GTT CCC TTC TGA CAA CT 582bp
NC17-B 201715- 201695 TTA GGT CCC CGT GCT TAC AC
NC19-A 201739- 201759 TAG GTG GAT CCA TAA CCC CA 480bp
NC19-B 202219- 202199 GGA CAG AGA AGC AGG AGT GG
NC20-A 202199- 202219 CCA CTC CTG CTT CTC TGT CC 487bp
NC20-B 202686- 202666 AAA GAA GAG CGA GCC CCT AC
NCI9Ex10-A 202593- 202612 CCA TAG CCC AAG AGC TTT CA 413bp
NCI9Ex10-B 203007-202987 GTA CCC GGC ATA ATC CAA GA
NCEx10I10-A 202986-203006 TTC TTG GAT TAT GCC GGG TA 403bp
NCEx10I10-B 203387-203367 TTT CCA GTT GGG GGT ACA CT
NC21-A 203296- 203316 GGG CTT CAA GGC CTA ATT CT 479bp
NC21-B 203775- 203755 ATG TGA TCC AGA CTG GCC TA
NC22-A 203654- 203674 ATG CAT GGG GTG TGG TAC TT 625bp
NC22-B 204277- 204255 TCC AAT GAT CTA CCT GTG TCC A
Table 4. Primer sequences used for primer walking spanning the entire region from Cftr exon 9 to Cftr
intron 10. Location based on the Genome Database Cftr sequence (AF 162137)
2.2.11)Sequencing.
 Following PCR amplification the chosen PCR products were sequenced by Qiagen GmbH
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2.3) Results
From the original CftrTgH(neoim)Hgu  mutant mouse generated using insertional mutagenesis in
the Cftr exon 10 (Dorin et al 1992) we have established two inbred CF lines CF/1-
CftrTgH(neoim)Hgu  and CF/3- CftrTgH(neoim)Hgu by strict brother sister mating. We have generated
three inbred congenic strains by backcrossing the targeted mutation to three different inbred
backgrounds C57BL/6, DBA/2J and BALB/c. To observe germline transmission of the
mutation after each backcross and after the first incross to develop homozygous congenic
strains, mice were genotyped using Southern Blot Hybridisation to indicate the transmission
of the insertional vector pIV3.5H (Figure 1). Since Southern analysis is cumbersome and time
consuming, we devised an alternative protocol for genotyping, whereby animals are
differentiated at the Cftr locus by intragenic microsatellite genotypes tightly linked with the
intron 9 and exon 10 of Cftr chosen for insertion mutagenesis in the CftrTgH(neoim)Hgu mouse
mutant.
2.3.1) Allele distribution between the strains. Consistent genotyping.
Four of the six tested Cftr intragenic microsatellite markers (D6NC3, D6NC2, D6Mit236 and
D6NC5) allowed the discrimination of the three inbred strains (C57BL/6, BALB/c, DBA/2J)
from the two inbred CF lines CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu  (Figure 2).
The two inbred CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu lines shared the same marker
alleles in all four informative microsatellites being distinct from the three inbred strains.
(Figure 2). Hence, a mouse homozygous for the disrupted locus can be identified by the
genotype: D6NC3:20/20, D6NC2:20/20, D6Mit236: 20/20, D6NC5: 20/20.  Accordingly, the
representative genotypes of a a) wild type BALB/c animal will be  (D6NC3: 16/16, D6NC2:
13/13, D6Mit236: 31/31, D6NC5: 30/30); b) wild type C57BL/6 (D6NC3: 14/14, D6NC2:
15/15, D6Mit236: 35/35, D6NC5: 21/21); c) wild type DBA/2J(D6NC3: 16/16, D6NC2:
13/13, D6Mit236: 44/44, D6NC5: 32/32).
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CftrTgH(neoim)Hgu n=17) were compared in the 1.2H probe restriction XbaI/SalI RFLP and
marker genotypes of the three informative intragenic Cftr microsatellites (D6NC3 intron1,
D6Mit236 intron 9, D6NC5 intron 18) equally distributed along the Cftr gene. Southern
RFLP and microsatellite marker genotypes were authenticated for 55 mice. Absence and
presence of the insertional mutation in intron 9/exon 10 in homozygous or heterozygous mice
could be clearly deduced from the microsatellite genotypes (Figure 2- Table 5).
1,2H D6NC3 D6Mit236 D6NC5
BALB/c
n/n 16/16 31/31 30/30 Homozygote wt
cf/n 16/20 31/20 30/20 Heterozygote mt
cf/cf 20/20 20/20 20/20 Homozygote mt
C57BL/6
n/n 14/14 35/35 21/21 Homozygote wt
cf/n 20/14 20/35 20/31 Heterozygote mt
cf/cf 20/20 20/20 20/20 Homozygote mt
DBA/2J
n/n 16/16 44/44 32/32 Homozygote wt
cf/n 20/16 20/44 20/32 Heterozygote mt
cf/cf 20/20 20/20 20/20 Homozygote mt
Table 5. Expected Southern and microsatellite genotypes for animals backcrossed to the three inbred
backgrounds.
2.3.2) Recombination.
Two genotypes (20/16, 20/31 20/20) mouse A and (16/16, 31/31, 20/20) mouse B (Table 6)
differed from the expected genotypes in the intragenic microsatellite D6NC5 in intron 18,
which is indicative for a recombination between CF/3- CftrTgH(neoim)Hgu and BALB/c
chromosomes 3´of the exon 10 of Cftr. Refined mapping with the three microsatellites
D6Mit50, D6NC3, D6Mit236 upstream of intron 18 and with the two microsatellites
D6Mit167 and D6Mit88 downstream of intron 18, revealed that recombinations had occurred
within the 100kb upstream  and 1.5Mb downstream of intron 18 in one chromosome in mouse
A and in both chromosomes in mouse B.
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HHX H S HH XH
1,2H
Exon 9 Exon 10pMC1neoPolyA
CFneo2 CFneo1
mouse 1,2H D6NC3 D6Mit236 D6NC5
A cf/n   cf/n(20/16)
cf/n
 (20/31)
cf/cf
(20/20)
B n/n   n/n(16/16)
n/n
 (31/31)
cf/cf
(20/20)
Table 6. Genotypes of the animals with recombination 3´of the Cftr gene
2.3.3) Excision of the pIV3.5H vector.
In two out of the 57 investigated animals the mutant genotypes as defined by Southern and
microsatellite genotypes were discordant (Table 7).
mouse 1.2H D6NC3 D6Mit236 D6NC5
C cf/n cf/cf(20/20)
cf/cf
(20/20)
cf/cf
(20/20)
D n/n   cf/cf(20/20)
cf/cf
(20/20)
cf/cf
(20/20)
Table 7. Genotypes of the animals with an excised vector. Mouse C in one chromosome, Mouse D in
both chromosomes.
In detail, mouse C was classified heterozygous CF by Southern and homozygous CF by the
microsatellites and mouse D homozygous wild type by Southern and homozygous CF by the
microsatellites. Genotyping via Southern Blot Hybridization indicates and depends upon the
existence or absence of the insertional vector pIV3.5H designed to disrupt the Cftr gene in
exon 10. Therefore, as a first step we tried to verify the presence or absence of the pIV3.5H
vector with a straight forward PCR assay that scans the ends of the heterologous vector
sequence (Figure 3).
Figure 3. Map position of the CFneo1 and CFneo2 products
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One PCR product scans the junctions between intron 9 and the inserted plasmid sequence, the
other PCR product the junction between the neo gene and the endogenous intron 9
encompassing the unique SalI site. The results of the PCR assays were consistent with the
Southern data i.e. for mouse C both insert specific products were present indicating an intact
vector on at least one chromosome, whereas for mouse D both products were absent. This
data strongly suggests that the pIV3.5H insertion vector had been excised from the CF/3-
CftrTgH(neoim)Hgu   Cftr locus at least in mouse D.
In order to corroborate this suspicion that the vector had been excised in both the
heterozygous and homozygous state a long range PCR protocol was established that
encompasses the targeted region in intron 9 and exon 10 for both wild type and mutant
chromosomes. Four sets of primers were designed (Table 3), one product of 5012bp
corresponding to wild type Cftr allele and three primer sets to the mutant allele with the
inserted sequence (Figure 4).
Figure 4. a) Map position of the long range PCR product corresponding to the 5012bp wild type
sequence. b) Map position of the three long range  products corresponding to the mutant allele. c)
Representative agarose gel (1%) indicating the expected PCR products for all four primer sets.    
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Mouse D was positive only for the 5012bp product confirming the absence of the pIV3.5H
vector on both chromosomes, whereas mouse C was positive for all four products indicative
of a CF heterozygous mouse. In mouse D the inserted vector had been excised from both
chromosomes, and in mouse C in one chromosome.
2.3.4) Primer Walking.
The sequence integrity of the complete homologous targeted region was checked by primer
walking. Fifteen sets of primers were designed from Cftr exon 9 to intron 10 (Table 4, Figure
5), and all products of the mutant mice were compared against the BALB/c wild type control.
PCR products suspicious for differential migration behaviour on 2.5% agarose compared to
those obtained from the wild type BALB/c DNA were sequenced.  For all five selected PCR
products including NC13 which corresponds to the area in Cftr intron 9 where the vector was
introduced via homologous recombination (Dorin et al., 1992) the sequence was found to be
100% wild type (BALB/c) with small sequence alterations when compared to the AF162137
database C57BL/6 derived sequence. Since the same substitutions were observed for the wild
type control they likely represent SNPs between the inbred strains BALB/c, 129P2 and the
C57BL/6. In summary, since sequencing by primer walking revealed neither any loss of wild
type Cftr sequence nor retention of vector sequence, we conclude that in the two mice the
pIV3.5H insertion vector had been excised by the base.
Figure 5. Primer walking. Straight lines represent the fragment amplified by each primer set,
overlapping sequences are represented by boxes.
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2.4) Discussion
Genetic analysis of complex human diseases such as cystic fibrosis has been successfully
supported by the use of various mouse models. In order to dissect the role of the different
induced mutations to the murine Cftr gene used from the genetic background, the genomic
section carrying the mutation is transferred by repeated backcross cycles to another defined
inbred background (introgressing), creating congenic strains. We have generated three
congenic CftrTgH(neoim)Hgu  strains by crossing the mutant animals to the three inbred
backgrounds BALB/c, C57BL/6, DBA/2J. In each generation germline transmission of the
disrupted Cftr locus was monitored using Southern Blot Hybridisation (Dorin et al., 1992). In
order to observe germline transmission of the disrupted Cftr locus we have established an
alternative ‘high-throughput’ genotyping protocol using Cftr intragenic microsatellites, which
enabled us to identify animals carrying the insertional mutation based upon  the different
haplotypic backgrounds of the three inbred strains and the mutant CF/3- CftrTgH(neoim)Hgu
inbred line at the Cftr locus.
The present study is to the best of our knowledge, the first deliberate search for polymorphic
intragenic Cftr markers for the establishment of Cftr haplotypic backgrounds of wild type
inbred mouse strains. It has been shown that some of the more common polymorphisms in the
human CFTR gene have consequences at the functional level. The presence of an allele at a
particular locus can determine the proportion of transcripts from which functional CFTR
protein can be translated affecting CFTR maturation and the net chloride transport activity of
CFTR-expressing cells (Cuppens et al., 1998). Although it remains to be proven whether
intragenic changes can substantiate for phenotypic variability in disease expression among
mice with different Cftr background carrying the same mutation, it can not be excluded that
they may have a potential effect on the severity of the CF phenotype by several mechanisms.
In our study the determination of the Cftr haplotypic backgroung provided a useful tool for
the identification of mutant animals. Using this protocol we have successfully verified the
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genotype of 55 out of 57 animals bred to the three inbred backgrounds, previously genotyped
by Southern blot hybridisation using the 1.2H probe.
2.4.1) Recombination.
 A result indicative for a recombination between CF/3- CftrTgH(neoim)Hgu  and BALB/c
chromosomes 3´of the exon 10 of Cftr was observed in two individual cases (mouse A and
mouse B). Refined mapping revealed that recombination had occurred within the 100 kb
upstream and 1.5Mb downstream of intron 18 in one chromosome in mouse A and in both
chromosomes in mouse B. Based on studies done on the human CFTR gene recombination
breakpoints have been identified between intron 10 and intron 18 and between intron 14a and
exon 18 (Morral et al., 1996; Dörk et al., 1992). The recombination frequency observed in our
study is in agreement with the human CFTR, with recombination being much more common
in the second half of human CFTR gene.
2.4.2) Excision.
In two separate cases (mouse C and mouse D) the Southern insertional mutation genotype
could not be verified with the three intragenic microsatellites. A heterozygous mouse C and a
homozygous wild type mouse D, as indicated via Southern blot hybridisation were
homozygous for the intragenic microsatellite genotype linked to the disrupted Cftr locus
(CF/3- CftrTgH(neoim)Hgu background). Further investigation on these two mice (see Results
section) revealed that the outcome of both genotyping methods was correct, supporting the
hypothesis of the event of pIV3.5H insertional vector being excised from the mutated Cftr
locus, on both chromosomes in mouse D and in one chromosome in mouse C. Primer walking
revealed that the 7.3kb vector has been excised precisely from the mutated Cftr locus without
causing any sequence alteration in the Cftr gene. Both mouse C and mouse D are the offspring
of animals heterozygous for the mutation. The mechanism responsible for this excision repair
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event must be independent from the mismatch repair (MMR) and nucleotide exchange repair
(NER) pathways, since the size of the vector overexceeds the maximum of mismatched
nucleotides they can efficiently repair (Corrette-Bennett et al., 2001; Fang et al., 2003;
McCulloch et al., 2003). The mechanism involved in the excision of the vector and the
subsequent restoration of the mutated Cftr locus to wildtype can not be gene conversion as
seen in other organisms (Kearney et al., 2001; Clikeman et al., 2001), because the genetic
background is conserved. If the mechanism involved large loop repair by incorporating the
vector in a heteroduplex there must be a novel mechanism, which is independent of gene
conversion-restoration events.
O type sequence insertion vectors (Dickinson et al., 1993) such as the pIV3.5H, contain an
uninterrupted stretch of target- homology with exonic sequence that results in duplication of a
large stretch of sequence flanking the heterologous sequence of the plasmid resembling
transposable elements, flanked by large direct repeats.  Reports (Scott et al., 1996) on precise
excision events of transposable elements without leaving a footprint involve an alternative
mechanism of repair rather than gene conversion which is dependent on length of the repeat
flanking the element. It is therefore highly likely that a similar mechanism is responsible for
the precise excision of the pIV3.5H insertion vector.
This is the first report where an O type vector used in order to generate insertion mutagenesis
in the mouse, has been excised. Such events probably remained unnoticed because most of the
methods used in order to identify animals which carry the targeted locus base their detection
almost exclusively on the presence or absence of the inserted sequence, without taking into
consideration the genetic background of the mouse strain adjacent to the insertion, therefore
an excision event would not be easily identified. Unlike Southern hybridisation the
genotyping protocol that we propose in this study does not indicate the presence of the
insertion vector directly based on the presence of its sequence in the disrupted locus, but
manages to discriminate insertional mutant animals from the haplotypes associated with the
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disrupted locus in the Cftr gene. In our study the haplotypes obtained from the three
informative intragenic Cftr microsatellites were differential to the haplotypes associated with
the insertional mutant mouse, allowing identification of excision events, or any other
alteration in the Cftr locus including recombination.
2.5) Conclusion
 Microsatellite markers spanning the mouse genome have been used for the enhancement of
congenic breeding, reducing the time to 18-24 months (speed congenics) from an initial 2.5 -3
year period (Wakeland et al., 1997; Visscher 1999). Here we describe the use of Cftr
intagenic markers which allowed fast and efficient identification of the differential locus
during backcrossing. Moreover, this method provided a useful tool whereby unexpected
events such as vector excision from the disrupted Cftr locus have been revealed posing
questions for the stability of insertional mutants generated by this strategy. Furthermore,
given our observations that different haplotypic backgrounds were found between the inbred
strains raises questions on whether alleles at polymorphic loci can affect cftr at the transcript
and/or protein level and whether it would be beneficial to study Cftr induced mutations on the
respective haplotypic background of the individual strains.
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Chapter 3
Phenotypic characterisation of CF/1- CftrTgH(neoim)Hgu and CF/3-
CftrTgH(neoim)Hgu
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Abstract
From the original CftrTgH(neoim)Hgu mutant mouse model with a divergent background we
have generated two inbred CftrTgH(neoim)Hgu mutant strains named CF/1- CftrTgH(neoim)Hgu
and CF/3-CftrTgH(neoim)Hgu using brother x sister mating for more than 20 generations.
Initial phenotypic characterisation on these two CF inbred strains indicated that they
differed in the levels of correctly spliced Cftr mRNA production. Low amounts of wild
type Cftr protein was detected for both strains in the intestine (CF/1- CftrTgH(neoim)Hgu
20% of wt, CF/3- CftrTgH(neoim)Hgu 10% of wt). Short circuit current measurements in the
respiratory and intestinal epithelium revealed that, both strains have ameliorated the
basic defect of cystic fibrosis with a presentation of a subnormal electrophysiology in
both tissues. On the basis of these findings both CF/1- CftrTgH(neoim)Hgu and CF/3-
CftrTgH(neoim)Hgu offer an excellent model whereby determination of the minimal levels of
protein required for the amelioration of the basic defect of CF can be studied, along with
the modulating factors which may affect this outcome.
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3.1) Introduction
Cystic fibrosis (CF) is a fatal autosomal recessive disorder characterised by defective chloride
transport in epithelial cells and excess mucus secretion (Davis et al., 1996). It is caused by
mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR), resulting
in defective cAMP-dependent chloride conductance (Riordan et al., 1989). Isolation of the
mouse Cftr gene enabled the modelling of the disease in the mouse by gene targeting in
embryonic stem cells. To date thirteen mouse models of CF have been reported in the
literature, with varying degrees of characterisation. Mouse models generated using a
replacement gene-targeting method to disrupt the Cftr gene (Cftrtm1Unc, Cftrtm1Cam, Cftrtm1Hsc,
Cftrtm3Bay) (Snouwaert et al., 1992, Ratcliff et al., 1993, Rozmahel et al., 1996, Hasty et al.,
1995) are absolute nulls with no wild type mRNA detectable. Models designed to mimic
human clinical mutations depending upon the strategy used have either normal (double
homologous recombination models, Cftrtm1Eur, Cftrtm2Hgu) (van Doorninck et al., 1995,
Dickinson et al., 2002) or reduced levels (replacement gene-targeting models Cftrtm1Bay,
Cftrtm1Kth, Cftrtm1G551D) (O´Neal et al., 1993, Zeiher et al., 1995, Delaney et al., 1996) of
mutant mRNA expression levels.
Dorin et al., (1992), described a transgenic mouse model CftrTgH(neoim)Hgu / CftrTgH(neoim)Hgu,
generated following targeted insertional mutagenesis into exon 10 of the murine Cftr gene in
embryonic stem cells. Unlike the Cftr mutants created by gene replacement low levels of wild
type Cftr mRNA are produced as a result of exon skipping and aberrant splicing (Dorin et al.,
1994). Further characterisation of this mixed genetic background insertional mouse model
indicated that it was viable, suffered from only mild intestinal obstruction with gut, lung and
gonadal pathology characteristics of cystic fibrosis. Despite their residual levels of wild type
mRNA CftrTgH(neoim)Hgu/CftrTgH(neoim)Hgu mutant mice displayed the electrophysiological defect
in the gastrointestinal and respiratory tract characteristic of CF and could be unequivocally
distinguished from their non-cf littermates (CftrTgH(neoim)Hgu /+ and +/+) on this basis (Smith et
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al., 1995). This argued that even though there is production of wild type mRNA there can
only be minimal functional Cftr protein sufficient to ameliorate the otherwise fatal intestinal
obstruction but not enough to ameliorate the intestinal electrophysiological disease phenotype
(Dorin et al., 1992).
From the original CftrTgH(neoim)Hgu mutant mouse model (Dorin et al., 1992) with a divergent
background we have generated two inbred CftrTgH(neoim)Hgu inbred mutant lines named CF/1-
CftrTgH(neoim)Hgu and CF/3-CftrTgH(neoim)Hgu using brother x sister mating for more than 20
generations. Phenotypic evaluation of the inbred CF/1-CftrTgH(neoim)Hgu and CF/3-
CftrTgH(neoim)Hgu animals indicated that both lines have ameliorated the basic defect of CF with
a presentation of a subnormal electrophysiology in both the intestinal and nasal epithelium.
Unlike leaky splicing mutations in the human the trace amounts of correctly spliced mRNA
and the subsequent low amounts of wild type Cftr protein substantiated for the amelioration of
the disease phenotype in the two inbred CftrTgH(neoim)Hgu strains. Based on this finding both
CF/1-CftrTgH(neoim)Hgu and CF/3-CftrTgH(neoim)Hgu offer an excellent model to determine the
minimal levels of wild type Cftr required to ensure a normal chloride secretory capacity of the
intestine preventing intestinal obstruction. Moreover, the mechanisms operating at the
transcriptional and translational level to ameliorate lethal mutations can be addressed.
56
3.2) Materials and Methods
3.2.1) Experimental animals
All experiments were approved by the local Institutional Animal Care and Research Advisory
Committee as well as by the local government. CftrTgH(neoim)Hgu mice were bred under
specified pathogen-free conditions in the isolator unit of the Central Laboratory Animal
Facility of the Hannover Medical School. Mice were kept in a flexible film isolator. The
temperature within the insulator was maintained at 20-24ºC with 40-50% relative humidity.
Animals were fed an irradiated (50 kGy) standard chow (SSniff) and autoclaved water (134ºC
for 50min) ad libitum.
3.2.2) Generation of inbred CftrTgH(neoim)Hgu mutant mice.
For the gene targeting and germline transmission to generate the CftrTgH(neoim)Hgu mice, the
embryonal stem cell line E14 was used (Dorin et al., 1992). E14 originates from the inbred
mouse strain 129 (subline 129/Ola-Hsd, abbreviated designation: 129P2). These cells were
injected into blastocysts of the inbred strain C57BL/6. The resulting chimeric offspring was
crossed to C57BL/6 and to the outbred strain MF1 for several times to increase reproduction.
 The inbred population of CftrTgH(neoim)Hgu mice was established from one pair with divergent
genetic background of one homozygous male and one homozygous female at generation F4.
Two separate litters were obtained and two animals of each litter became the starting
population for the establishment of the two individual inbred CftrTgH(neoim)Hgu lines CF/1-
CftrTgH(neoim)Hgu and CF/3-CftrTgH(neoim)Hgu which were generated by brother-sister mating for
now more than 26 generations.
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3.2.3) Isolation of RNA and RT-PCR.
Tissue samples from the intestine were immediately frozen in liquid nitrogen after extirpation
and stored at -70ºC until use. Prior to RNA isolation, all solutions and plastic equipment were
treated for at least 12 h with 0.04% aqueous diethyl pyrocarbonate solution. RNA was
isolated from the homogenized tissue as described by Chomczynski et al., 1987. In brief,
following isopropanol precipitation, the RNA pellet was precipitated with isopropanol and
prepared for storage at -70ºC. The absence of contamination by DNA was verified by PCR.
mRNA was converted to cDNA and subjected to amplification by PCR with Taq polymerase
(InviTaq). For the detection of the correctly spliced mRNA the wild type mouse Cftr cDNA
was amplified with a sence exon 9 primer 5´GCT ATT ACT GGA TCT ACT GGA CTA GG
and an antisense exon 13 primer 5´GCT CGG ACG TAG ACT TTG TAG C. The PCR
reaction was carried out at 58ºC annealing for 1 min, 72ºC extension for 1 min, and 92ºC
denaturation for 30 sec. cDNA from MF1 wild type mouse were used as controls.
3.2.4) Sequencing.
Following RT-PCR cDNA products were sequenced by Qiagen GmbH.
3.2.5) Western Blot analysis.
Wild type MF1 mice and CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu mutant mice were
anaesthetized with a hypnorm/diazepam mixture. Their abdomens were opened and their
small intestines dissected. Epithelial cells originating principally from the villus region were
isolated at 0-4ºC from the jejunum by everting the intestinal segments on metal rods attached
to a vibration apparatus (Vibromixer type E1 from Chemap A.G.) and exposing them to
vibration (50 Hz, amplitude 1.5 mm) for 30 min in 0.14 M NaCl containing 5 mM EDTA pH
7.4. Detached jejunal enterocytes were collected by centrifugation at 800 g for 15 s and
suspended in 10 ml of a medium containing 12 mM Tris-HCl pH 7.4, 0.3 M mannitol, 10 mM
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KCl, 0.5 mM EDTA and a protease-inhibitor cocktail containing 0.3 mM Pefablock
(Boehringer Mannheim Germany), 10 µg/ml aprotinine, 5 µg/ml leupeptine, 1 µg/ml pepstatin
A, 1 µg/ml chymostatin, 50 µg/ml soybean trypsin inhibitor and 0.03 g/l phosphoramidon.
Vesiculation of intestinal membranes was achieved by a freeze-thaw procedure described
initially for rat enterocytes and crude microsomal membranes were isolated from half of the
cell lysate by a two-step differential centrifugation procedure (10 min, 4000 g, followed by 60
min, 40 000 g). The other half was used to isolate BBMV by differential precipitation with 10
mM MgCl2 and differential centrifugation (15 min, 3000 g followed by 30 min, 27 000 g)
essentially as described by van Dommelen et al., (1986). The membrane pellets were
solubilized by vortexing in 30 µl modified Laemmli sample buffer [0.06 M Tris-HCl; 2%
(w/v) SDS, 10% (w/v) glycerol, 0.1 M dithiothreitol, 0.1% (w/v) bromophenol blue and the
protease inhibitor cocktail, pH 6.8] and incubated for 30 min at room temperature. Following
centrifugation (2 min, 8000 g) samples of the supernatant (10 µl, adjusted to 20 µg protein)
were separated on 6% polyacrylamide slabgels using a Bio-Rad Miniprotean apparatus (Bio-
Rad Laboratories). Proteins were subsequently electroblotted onto nitrocellulose paper (0.1
µm pore size; Schleicher and Schuell) in 0.025 M Tris, 0.192 M glycine, 20% (v/v) methanol.
The blots were incubated overnight at 4ºC with 0.02 M Tris-HCl, 0.15 M NaCl, 0.1% (w/v)
Tween 20 pH 7.5 (TTBS), followed by overnight incubation at 4ºC with a 1:1000 dilution of
affinity-purified anti-CFTR antibody R3195 in TTBS. Blots were washed three times in
TTBS, incubated with peroxidase-conjugated anti-rabbit IgG (Tago Inc.; 1:3000 in TTBS for
2 h), and washed four times with TTBS. Peroxidase activity was detected with
bioluminescence reagent (ECL kit; Amersham) on X-ray film, and CFTR bands were
quantitated with the Molecular Imaging System GS-363 (Bio-Rad).
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3.2.6) CFTR antibody.
The rabbit polyclonal antibody R3195 was raised against a thyroglobulin-conjugated 13
amino acid COOH-terminal peptide sequence of rodent CFTR and was affinity purified on a
peptide epoxide-activated Sepharose column, eluted with 4.9 M MgCl2, dialysed and
concentrated. CFTR labelling specificity has been demonstrated previously in western blot
and immunocytochemical assays by the loss of immunostaining in tissue specimens from
CFTR-/- mice (French et al., 1996).
3.2.7) Immunocytochemical analysis.
Wild type and mutant CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu mice were sacrificed
by cervical dislocation, the intestine was dissected and the jejunum, duodenum and ileum
were rinsed with ice-cold saline and fixed in 3% (w/v) paraformaldehyde for 16 h, prior to
standard paraffin embedding. Sections (5 µm) were deparaffinised, followed by microwave
treatment in 0.01 M sodium citrate solution according to Devys et al., (1993) Endogenous
peroxidase activity was blocked by a 30 min preincubation in 0.1 M PBS, 0.6% (v/v) H2O2
and 0.12% (w/v) sodium azide. Subsequently, sections were incubated with antibody R3195
(1:100) at room temperature for 1 h followed by a 45 min incubation with a peroxidase-
conjugated secondary antibody. Enzymatic detection of antigen-antibody complexes was
achieved by incubation in substrate solution containing H2O2 and 3,3´-diaminobenzidine
tetrahydrochloride (DAB; Serva). Finally, the sections were counterstained with
haematoxylin. Labelling specificity was verified by incubations without primary antibody. In
both cases, background labelling appeared negligible.
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3.2.8) Short current measurements.
Freshly excised mouse ileum and nasal epithelium of CF/1-CftrTgH(neoim)Hgu and CF/3-
CftrTgH(neoim)Hgu homozygous animals were used for short circuit measurements (SCC) and
compared with wild type controls. Experiments were performed at 37ºC. The basic perfusion
solution (modified Meyler`s solution) consisted of 105 mM NaCl, 4.7 mM KCl, 1.3 mM
CaCl2, 1.0 mM MgCl2, 20.2 mM NaHCO3, 0.4 mM NaH2PO4, 10 mM HEPES, saturated with
95% O2 and 5% CO2, pH 7.4.
Mouse ileum was excised under hypnorm/diazepam anaesthesia and reverted on a plastic rod.
The muscle layer was cut longitudinally using a blunt razor blade and was stripped of fat
manually. The stripped tissue was mounted in a holder with the mucosal side up (exposed
tissue area 0.2 cm2). After insertion of the holder into the Ussing chamber the tissue was
allowed to recover for 10-20 min and to reach a stable baseline. To the serosal side of the
ileum glucose (10 mM) and indomethacin (10 mM) were added. After equilibrium, the
following compounds were added to the mucosal (M) or serosal (S) side of the tissue:
Forskolin (10 µM, S), genistein (100 µM, M+S)  and carbachol (200 µM, S). All compounds
were present throughout the experiment.
Mouse nasal epithelium was isolated as described by Grubb et al., (1994). In brief the mice
were sacrificed by servical dislocation and the skin of the head was peeled back in order to
reach the underlying paired nasal bones. These were removed and the two sheets of the nasal
epithelia, separated by the septum, were isolated independently. The sheets of epithelia were
mounted immediately between the Ussing chambers (exposed area 1.13 mm2). The chambers
were filled with gassed modified Meyler`s solution supplemented with glucose (10 mM) and
indomethacin (10 mM) and the short circuit measurements were started. After equilibration
amiloride (10 µM, M) was added followed by forskolin (10 µM, M after stabilization of the
current).
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3.2.9) CFTR immunostaining in mouse nasal epithelium.
For immunocytochemical staining of nasal epithelium the tissue was treated as described
above. In case of immunofluorescent staining the sections were incubated with the primary
antibody CFTR 3195 (1:100) for 1.5 h followed by the incubation with goat-anti –rabbit FITC
(Nordic) labelled secondary antibody (1:100) for 45 min.
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3.3) Results
3.3.1) Generation of the inbred CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu  mutant
mice.
From the original CftrTgH(neoim)Hgu  mutant mouse generated using insertional mutagenesis in
the Cftr exon 10 (Dorin et al., 1992) we have established two inbred CF strains CF/1-
CftrTgH(neoim)Hgu  and CF/3- CftrTgH(neoim)Hgu by strict brother sister mating for now more than 26
generations.
3.3.2) Cftr mRNA analysis.
In order to determine whether CF/1-CftrTgH(neoim)Hgu  and CF/3-CftrTgH(neoim)Hgu animals
produce wild-type Cftr mRNA, we used RT-PCR spanning exon 9 to exon 13, using MF1
wild type animals as positive controls. Wild type mRNA corresponded to a cDNA product of
555 bp in size. For the inbred line CF/1- CftrTgH(neoim)Hgu faint but otherwise pure bands were
detected corresponding to the expected appropriate size indicative of only trace amounts of
correctly spliced mRNA in these mice. No signal was detected for the CF/3- CftrTgH(neoim)Hgu
inbred line arguing for either extremely reduced to absent production of correctly spliced Cftr
mRNA in these animals.
Sequencing of the PCR products obtained for the CF/1- CftrTgH(neoim)Hgu mutant mice revealed
that the observed trace amounts correspond 100% to wild type Cftr cDNA sequence.
The previously described (Dorin et al., 1994) alternatively spliced mRNA encompassing the
206 bp fragment from the targeting vector pIV3.5H which is spliced between exon 9 and 10
was not detected in any of the samples examined in this study.
3.3.3) CFTR processing in CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu mutant mice.
Analysis of  brush border membrane vesicle (BBMV) preparations consisting of apical
membranes of mutant homozygous CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu mice
demonstrated the presence of  fully glocosylated isoform (band C) of CFTR in these mice
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(Figure 1). The intensity of the C band of these mice was reduced when compared with the
intensity of the C band of the wild type MF1 mice (n=2).
Wild Type   CF/1, CF/3
     Dil: 1x       2x    5x      10x (pooled samples)
Cftr Band C
      180kDa
          % Wt  100     50       20       10                           20         10
Figure 1. Quantification of wild type Cftr protein in apical membranes of CF/1- CftrTgH(neoim)Hgu and
CF/3- CftrTgH(neoim)Hgu mutant mice. BBMV isolated from wild type MF1 mice were subjected to
western blot analysis as described in Materials and Methods. Blots were labelled using the CFTR-
specific R3195 antibody.
By running pooled samples of the CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu mutant
mice together with serial dilutions (5x, 10x, 20x, 50x, 100x) of membranes from the MF1
wild type mice the amount of mature CFTR (band C) in the two inbred mutant mice was
estimated to be 20% of wild type for CF/1- CftrTgH(neoim)Hgu and 10% of wild type Cftr protein
for CF/3- CftrTgH(neoim)Hgu.
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3.3.4) Phenotype of the inbred CF1- CftrTgH(neoim)Hgu and CF3- CftrTgH(neoim)Hgu mutant
mice.
Homozygous CF/1-CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu mice do not show any increased
mortality over wild type animals (pre-or post weaning) weight does not differ significantly
from wild type (MF1) and both males and females are fertile.
Histological analysis of intestinal sections (jejunum, ileum, duodenum) revealed focal
hypertrophy of goblet cells in the CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu
homozygous mutant mice (Figure 2).  This hypertrophy, is more severe than that observed in
the Cftrtm1Eur and Cftrtm2Hgu mice.
3.3.5) CFTR immunocytochemistry.
Wild-type FVB mice showed strong apical Cftr-immunoreactive staining of crypts throughout
the gastrointestinal tract whereby intensity decreased continuously from duodenum to
terminal ileum. In inbred CF/1- CftrTgH(neoim)Hgu mice staining with the R3195 Cftr antibody
revealed weak and mainly diffuse signals with some apical labelling in the upper villus region
of the ileum, whereas no specific immunoreactive signals could be detected in sections from
duodenum and jejunum (Figure. 2). Sections of the intestine of CF/3- CftrTgH(neoim)Hgu mice
showed substantially weaker staining at the limit of detection.
Cftr immunostaining of nasal respiratory epithelium (Figure 3) yielded strong punctuated
apical labelling of similar intensity in CF/1- CftrTgH(neoim)Hgu, CF/3- CftrTgH(neoim)Hgu and FVB
wild type, with the F508del homozygous mice exhibiting much fainter signals.
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     A    B       C
     D    E       F
Figure 2. Immunohistological analysis of CftrTgH(neoim)Hgu Cftr expression. Immunocytochemical
staining of Cftr in the duodenum (A), jejunum (B) and ileum (C) of the CF/1- CftrTgH(neoim)Hgu and in
the duodenum (D), jejunum (B) and ileum (C) of CF/3- CftrTgH(neoim)Hgu. Examples of goblet cells are
indicated in black arrows.
      A B
      C D
Figure 3. Cftr immunostaining in the nasal epithelium of a wild type FVB mouse (A), homozygous
F508del (B), CF/1- CftrTgH(neoim)Hgu (C) and CF/3- CftrTgH(neoim)Hgu (D).
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3.3.6) Electrophysiological characteristics of CF/1-CftrTgH(neoim)Hgu and CF/3-
CftrTgH(neoim)Hgu.
The electrophysiological profile of CF/3- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu mice both
in the nose and the intestine was examined by current measurements of ion secretory
responses in Ussing chambers under short-circuit conditions. The chloride secretory responses
of homozygous CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu mice were compared with
those of wild type animals (FVB) and of Cftrtm1Eur F508del homozygous mutant mice. Basal
ion flow was similar in wild type and all examined CF strains (Figure 4). The chloride
secretory response evoked by forskolin which activated the Cftr through an increase in cAMP
amounted to about 50% of that observed in wild type animals and was significantly higher
than that of F508del homozygous mice. The response of CF/1- CftrTgH(neoim)Hgu and CF/3-
CftrTgH(neoim)Hgu to carbachol was intermediate between wild type and F508del homozygous
mice. In contrast genistein which sustains the open state of CFTR channels generated larger
short circuit current (SCC) currents in F508del than in CF/1-CftrTgH(neoim)Hgu and CF/3-
CftrTgH(neoim)Hgu  mice.
In the nasal respiratory epithelium CF/1-CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu mice
exhibited an intermediate phenotype between wild type and F508del mice with respect to
short circuit current (SCC) (Figure 5) under basal conditions and exposure to amiloride which
blocks sodium reabsorption. Interestingly, the forskolin cAMP- activated chloride secretory
response was indistinguishable from wild type in all three examined CF models.
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Figure 4. Bioelectric characteristics of the CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu in the
ileum, compared with those of wild type and homozygous F508del mice.
Figure 5. Bioelectric characteristics of CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu in the nasal
epithelium compared with wild type and F508del homozygous mutant mice.
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3.4) Discussion.
3.4.1) CF1- CftrTgH(neoim)Hgu and CF3- CftrTgH(neoim)Hgu express trace levels of wild type Cftr
mRNA and low amount of protein
In agreement with a previous study on the outbred CftrTgH(neoim)Hgu (Dorin et al., 1994) the
expected mutant mRNA with an intact vector sequence was not detected in either of the two
inbred strains. Moreover, the previously described (Dorin et al., 1994) novel mRNA
encompassing a 206 bp fragment from the targeting plasmid vector pIV3.5H spliced between
exon 9 and 10 was also not detected in either one of the two inbred strains.
RT-PCR from exon 9 to 13 revealed only trace levels of normal message in CF/1-
CftrTgH(neoim)Hgu homozygous CF animals but failed to detect any levels of correctly spliced
Cftr mRNA in CF/3- CftrTgH(neoim)Hgu (cf/cf) animals in the intestine.
Consistent with the mRNA analysis western blot analysis on BBMV revealed that CF/1-
CftrTgH(neoim)Hgu produce approximately 20% of wild type levels of Cftr protein, moreover the
same analysis showed that CF/3- CftrTgH(neoim)Hgu (cf/cf) animals produce wild type Cftr
protein in their enterocytes which is approximately 10% of wild type and hence two fold
reduced compared with CF/1- CftrTgH(neoim)Hgu. The latter indicated that even though mRNA
levels were below the level of detection for the CF/3- CftrTgH(neoim)Hgu animals, wild type
protein is present indicating that splicing of the insertional mutation takes place in both inbred
CftrTgH(neoim)Hgu mouse strains.
3.4.2) Electrophysiological phenotype in the intestinal and nasal epithelium.
Despite the apparent absence of pulmonary pathology, electrophysiological analyses of the
various CF mouse models have been able to differentiate between mutants and wild type
littermates. Studies characterising the electrophysiological profiles of the intestines have
found broadly the similar phenotypes in the different models. CF mouse models display a
significant decrease in the baseline potential difference (PD) and short-circuit current (Isc) in
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the intestine. The mild nature of intestinal disease in Cftrtm1Eur F508del and Cftrtm2Hgu mice is
less clear but is probably due to a significant fraction of protein that is able to escape the
quality control mechanism in the ER and travel to the cell surface In the nose CF mouse
models in common with individuals have a raised basal potential difference (PD) indicating a
defect in sodium absorption.
Unlike mice with a complete disruption of Cftr expression, inbred homozygous CF1-
CftrTgH(neoim)Hgu and CF3- CftrTgH(neoim)Hgu mutant mice do not suffer from intestinal blockage
similar to Cftrtm2Hgu and Cftrtm1Eur mutant mice. CF1- CftrTgH(neoim)Hgu and CF3- CftrTgH(neoim)Hgu
mutant mice do not show a defect in their forskolin response in the intestine with the baseline
and carbachol response not altered compared to wild type. In the nose the forskolin response
in both CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu mice was not different from wild
type. Overall the electrophysiological phenotype suggested that unlike their outbred
progenitor the two inbred CF strains managed to ameliorate the basic defect by utilising
mRNA levels greatly reduced from those described in the original report by Dorin et al.,
1994.
3.4.3) Mechanisms of function.
3.4.3.1) Selection during inbreeding.
One can speculate that this phenotypic outcome is a direct result of selection during the
inbreeding procedure. The selected mechanism responsible for this outstanding outcome
should relate to those cellular processes which are involved in both the transcriptional and
translational level influencing mRNA stability and protein processing in these mice.
Moreover, the bioelectric phenotype between CF/1-CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu
regardless of the variation observed between the protein levels of the two inbred strains could
be explained by the effect of modifier genes present in the genetic background of the two
strains. Genome wide scan using microsatellite markers for every 20 cM showed that there is
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an approximate 15% divergence between the two strains arguing for the existence of modifier
loci responsible of rendering CF3-CftrTgH(neoim)Hgu to have a better differential regulation
compared to CF1-CftrTgH(neoim)Hgu.
3.4.3.2) At the level of transcription.
The introduction of the vector sequence introduces an unnaturally large exon in the murine
Cftr gene. Vertebrate internal exons are usually between 50 and 400 nt long; exons outside
this size range may require additional exonic and/or intronic sequences to be spliced into the
mature mRNA. Bruce and Peterson (2001) using  exon 4 of mouse polymeric
immunoglobulin receptor gene (654nt) showed that for the efficient splicing of large exons a
strong 5´splice site is necessary  along with two exonic sequences and one evolutionary
conserved intronic sequence in order for the exon to be spliced intact. Also, sequences that
enhance cryptic splice site use must be absent from this large exon. In the case of the
insertional vector pIV3.5H, used for the generation of the CftrTgH(neoim)Hgu , activation of such
cryptic splice sites in the plasmid sequence gave rise to the novel 206bp exon (Dorin et al.,
1994) providing an alternatively spliced mRNA. This alternatively spliced mutant mRNA
contains an in-frame stop at a position less than half way into the message. Skipping of exons
containing premature stop codons (PTCs) has been demonstrated in several human genetic
diseases (Bach et al., 1993, Dietz et al., 1993, Gibson et al., 1993, Hull et al., 1994) whereby
the outcome is an abnormally spliced mRNA induced by a PTC in the skipped exon. Urlaub et
al., (1989) have suggested a nuclear-scanning model, in which specific intranuclear factors
are able to scan the primary transcripts for premature termination codons (PTCs). In our case
of the novel mutant mRNA, subjection to exon skipping will result in the alternative splicing
of the new plasmid derived exon allowing for a wild type correctly spiced mRNA (Figure 6).
In the human the alternative splicing of many pre-mRNAs is affected by the intracellular
concentrations of antagonistic splicing factors of the serine-arginine rich (SR) family and
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hnRNPA1 (Zahler et al., 1993, Caceres et al., 1994,  Muro et al., 1999). Pagani et al., (2000)
showed that a protein complex containing SR proteins binds to the intronic splicing silencer
(ISS) elements in the CFTR intron 9 and represses splicing of exon 9, an inhibitory effect on
exon 9 splicing was also demonstrated for the splicing factor hnRNPA1. However, the
comparison between the human and murine CFTR slice variants showed that in the mouse the
alternative splicing of exon 9 is not evolutionary conserved (Delaney et al., 1993).
Figure 6.  mRNA splicing. a) Structure of the insertional mutation in the Cftr gene. Black b
represent exons, black and white squared boxes represent introns, gray boxes represent pla
sequence, lines represent the neomysin gene. Abbreviation stand for: H: HindIII, S: SalI.; b) pred
mRNA product from the mutant gene utilizing neo gene poly A addition signals; c)  novel m
mRNA deriving from the utilisation of cryptic splice sites in the plasmid sequence, resulting
plasmid derived exon of 206 bp.; d) the sequence of the novel mRNA contains an in-frame st
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3.4.3.3) Efficient protein processing mechanism.
The phenotypic observations provide evidence for the existence of a more powerful protein
processing mechanism in both CF1- CftrTgH(neoim)Hgu and CF3- CftrTgH(neoim)Hgu. Wild type
CFTR matures inefficiently, as less than 30% of the protein produced in heterologous
expression systems is converted into its fully glycosylated form (Ward et al., 1994) and it has
been shown to undergo degradation through the ubiquitin-proteosome pathway (Ward et al.,
1995). In vivo studies have suggested that molecular chaperones facilitate CFTR folding and
maturation, namely heat-shock cognate (Hsc) 70/Hsp 70 (Yang et al., 1993), human DnaJ
homologue (Hdj)-2 (Meacham et al., 1999) and Hsp90 (Loo et al., 1999) in the cytoplasm,
and calnexin (Pind et al., 1994). Co-expression of Hsp70 and its co-chaperon Hdj-1/Hsp40
results in the stabilisation of the endoplasmic reticulum (ER) immature form of wild type
CFTR, however over expression produces no significant effect on the conversion of the
immature form of wild type CFTR into its fully glycosylated form. Based on these
observations we can not exclude the possibility that such chaperones may play a key role in
the stabilisation of the low levels wild type Cftr protein in the two inbred mouse strains CF1-
CftrTgH(neoim)Hgu and CF3- CftrTgH(neoim)Hgu at the early stage of Cftr biogenesis, distinct from
the events that cause its escape from the endoplasmic reticulum.
Furthermore, elimination of the mutant mRNAs will result in the accumulation only of the
reduced amounts of correctly spliced mRNA preventing endoplasmic reticulum overload
response (EOR), which is initiated by the accumulation of wild-type or misfolded proteins in
the ER (Pahl 1999). This reduction in the ER stress may result in a more efficient processing
of the wild type Cftr message.
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3.4.3.4) Efficient Cftr protein trafficking and improved functional capacity at the apical
membrane.
The forskolin-genistein induced CFTR-mediated chloride current for CF/1- CftrTgH(neoim)Hgu
and CF/3- CftrTgH(neoim)Hgu in the small intestine was reduced to about 50% of wild type level,
implying that about 10% of mature wild type Cftr protein in the apical membrane is required
to ensure subnormal transepithelial intestinal currents providing evidence that both mutant
mice have higher efficacy compared with the wild type to generate functional protein in their
apical membrane. This could be the result of a) efficient Cftr trafficking from the post-ER
compartment to the apical membrane resulting in a higher proportion of mature protein
localisation in the apical membrane compared to the subapical compartment; b) higher
functional capacity of the Cftr channels in the apical membrane.
a) Cftr trafficking. Various components have been shown to influence maturation and
trafficking of CFTR from the ER/Golgi compartment to the basolateral and apical
compartments i.e. COPI-coated vesicles (Orci et al., 1997); PDZ-containing proteins such as
Csp (Zhang et al., 2002), EBP50 (Yun et al., 1997, Lamprecht et al., 1998), E3KARP (Yun et
al., 1997), CAP70 (Wang et al., 1999), CAL (Cheng et al., 1999), SNARE proteins (Low et
al., 1998), BAP31 (Lambert et al., 2001) and numerous Rab proteins. Early
immunocolocalisation and surface biotinylation studies in T84 colonocytes and Chinese
hamster ovary (CHO) cells stably transfected with CFTR showed that approximately 50% of
the total pool of mature CFTR in the cell is localised at the plasma membrane and 50%
localised intracellularly, suggesting the existence of a large subapical CFTR pool (Lukacs et
al., 1992 ). The functional phenotype of CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu
provide evidence that endocytosis and recycling of Cftr between the plasma membrane and
intacellular compartments in the two strains is regulated so that a higher proportion of mature
Cftr is targeted at the apical membrane. Endocytic recycling of membrane proteins is an
important process that contributes to the fine tuning of membrane protein activities due to
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environmental responses. The early endosomes are thought to be an important sorting station
whereby proteins are targeted to the late endosomes or recycled back to the plasma
membrane. Lukacs et al., 1997 demonstrated that budding prevention of clathrin-coated
vesicles resulted in a depletion of the CFTR content of early endosomes. Webster et al., 1994
showed that in the ductal epithelium of submandibular glands, CFTR is co-localised with
Rab4 which is a regulator of membrane traffic from early endosomes back to the apical
membrane. A higher proportion of mature Cftr in the apical membrane compartment in CF/1-
CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu mice could be due to a vesicle distribution of Cftr
throughout the cell whereby targeting to the late endosomes is avoided and premature
lysosomal degradation is reduced.
b) Activation of Cftr chloride channels. In agreement with the differential effect of genistein
on F508-CFTR channels (Hwang et al., 1997) the forskolin-genistein induced CFTR-
mediated chloride current observed for the Cftrtm1Eur F508del homozygous mutant mouse
model was increased compared to CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu. Moreover,
the forskolin-genistein induced chloride conductance suggests that even though there is a
lower estimated channel density in the CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu
compared to wild type in the apical membrane the proportion of active channels i.e. at an
open state, is higher compared to wild type. It is believed that protein kinase A (PKA)
activates CFTR by phosphorylating multiple serine residues in the R domain (Wang et al.,
2000). The partially phosphorylated CFTR channel has a lower open probability (Po) with
characteristic prolonged closing times (Hwang et al., 1994). Wang et al., 1998 demonstrated
that when the CFTR channel is strongly phosphorylated, the Po is increased with a
concomitant shortening of the closed time. Phosphorylation of the regulatory domain is
accomplished primarily by elevation of cAMP and activation of PKA therefore if increased
Cftr phosphorylation is to be considered as a factor influencing the higher efficacy of the Cftr
channels in CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu  it would require an increase in
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the levels of cAMP with the subsequent activation of the co-expressed  β2 adrenergic receptor
which increase cAMP levels.
Following phosphorylation by PKA, the opening and closing of phosphorylated CFTR
channels is coupled to ATP hydrolysis at NBD1 and NBD2 (Gadsby and Nairin 1999).
Electrophysiological evidence supports the hypothesis that hydrolysis of ATP is essential for
normal opening and closing or gating of the channel (Li et al., 1996). Several models have
been proposed to account for the regulation of channel gating by ATP hydrolysis (Carson et
al., 1995, Gadsby and Nairin 1994, Gunderson and Kopito 1995). An important point from all
the models proposed is that there is an irreversible cycle of gating due to the high free energy
of ATP binding and hydrolysis and that ATP concentration is an important determinant of the
closed time between bursts of activity. Therefore, in the case of CF/1- CftrTgH(neoim)Hgu and
CF/3- CftrTgH(neoim)Hgu  the adaptive mechanism influencing increase of the Cftr channel
activity i.e. the open probability (Po), is also linked to high available levels of ATP in these
two mice. During inbreeding selection of breeding partners was based on the selection of
those animals that were capable of producing sufficient litters and showed no severe disease
symptoms. It is therefore plausible to assume that during the repeated cycles of inbreeding a
mechanism may have evolved with a direct impact on the increase of ATP concentrations in
the two strains. Such a mechanism should involve those signal transduction pathways which
have a direct impact on the increase of energy metabolism in the two strains with a
subsequent increase in the ATP stores.
3.4.5)Comparison with the human.
Unlike with what is seen in the CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu mouse models
in the human the amount of correctly spliced mRNA produced by apparently leaky alleles is
not enough in order to ameliorate the disease severity in such a successful manner. Mutations
affecting the splicing of the cystic fibrosis transmembrane conductance regulator (CFTR)
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gene that lead to the simultaneous presence of correctly and aberrantly spliced transcripts
cause CF disease due to insufficient levels of the normal mRNA, and hence, functional
protein. Studies have reported a wide range of normal CFTR transcripts, from less than 4% to
less than 20% ( Chu et al., 1993, Rave-Harel et al., 1997), associated with “leaky” splicing
mutations in the human. For the 3849+10kb C>T mutation, a CF allele associated with mild
lung disease, pancreatic sufficiency and male infertility Highsmith et al (1994) reported 8% of
normal CFTR mRNA. The mutation 2789+5G>A, resulting in a similar pulmonary and
pancreatic phenotype but with male infertility has been reported (Highsmith et al., 1997) to be
associated with lower levels of correctly spliced CFTR mRNA (4%). Whereas Ramalho et al.,
2002 postulated that 5% of full-length CFTR mRNA in patients with 3272-26A>G/F508del is
enough to ameliorate the severity of CF disease, because in these patients most clinical
symptoms, including lung function and pancreatic involvement, are attenuated by comparison
to patients with two severe mutations.
Several reasons could attribute to this observed discrepancies 1) Both 3849+10kb C>T and
2789+5G>A alleles produce alternatively spliced transcripts which bear premature
termination signals. Nonsense mediated decay (NMD) a process by which cells recognise and
degrade nonsense mRNAs to prevent possibly toxic effects or truncated peptides, enhances
the degradation of messengers bearing premature stop codons in a process which is also
described for CFTR transcripts (Will et al., 1995). Therefore one has to discriminate between
the amount of different mRNA species produced and how  these are being further processed;
2) Moreover simultaneous processing of the mutant protein along with the wild type CFTR
will result in the increase of the ER stress because of the accumulation of misfolded proteins.
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3.5) Conclusion
This study demonstrates that low amounts of protein can substantiate for subnormal
phenotypic outcome in two inbred of CF strains. This amelioration of the basic defect defers
substantially from the phenotype reported for the outbred CftrTgH(neoim)Hgu whereby aberrant
splicing of the construct and subsequent production of wild type Cftr mRNA did not
substantiate for a correction in the electrophysiological phenotype indicating the existence of
a modulating factor which has evolved during the inbreeding procedure in these two strains.
Overall unlike any other mouse model described so far CF/1- CftrTgH(neoim)Hgu and CF/3-
CftrTgH(neoim)Hgu mutant mice provide a very good model whereby modulating factors involved
in the amelioration CF disease at the level of transcription and protein processing and
trafficking can be studied.
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Chapter 4
Microsatellite genotyping of the two CF inbred strains (CF1-
CftrTgH(neoim)Hgu and CF3- CftrTgH(neoim)Hgu) and the three inbred
strains (BALB/c, C57BL/6, DBA/2J).
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4.1) Introduction
4.1.1) The laboratory mouse
One of the advantages working with mice is the availability of a large variety of inbred
strains. The commonly known inbred strains originated almost exclusively from the fancy
mice purchased by geneticists from pet mouse breeders like Abbie Lathrop and others at the
beginning of the 20th century (Silver 1995). Fancy mice had their origins from native animals
captured in Japan, China, and Europe. Laboratory strains have a mosaic genome deriving
from more than one species (Wade et al., 2002) and today’s classical laboratory strains are
regarded as interspecific recombinant strains deriving from four parental components: Mus.
m. domesticus (Western Europe), Mus. m. musculus (Eastern Europe), Mus. m. castaneus
(Southeast Asia) and Mus. m. molossinus (Japan). Mus. m. molossinus is thought to be a
hybrid between castaneus and musculus. An inbred strain is considered to be genetically
uniform (isogenic) and with the use of the same standard inbred strain it is possible to
eliminate genetic variability as a complicating factor.
Strain Color Origin and Characteristics
BALB/c Albino
A, b, c
Stock acquired by H.Bagg in 1913, to MacDowell, to Snell in 1932
(who added the /c). Widely distributed and among the 2-3 most
widely used inbred strains. Used in immunological studies, well
known for the production of plasmacytomas on injection with
mineral oil. Good breeding performance and long reproductive life-
span. Data on genetic markers suggest that substrains have
divergent largely through mutation or residual heterozygosity rather
than genetic contamination.
C57BL/6 Black
a
Substrain of C57BL (Little 1921) separated prior to 1937. Standard
strain for genetic studies. It carries a Y chromosome of Asian Mus
musculus origin (AKR and SWR) (Tucker et al 1992). And a LINE-1
element derived from Mus spretus the frequency of which suggests
that up to 6.5% of the genome may be of M. spretus origin (Rikke
et al 1995). Good reproductive performance.
DBA/2 Dilute
Brown
a, b, d
Substrain of the oldest of all inbred strains of mice (dba, Little
1909). Differences between the substrains are probably too large to
be accounted for by mutation, and are probably due to substantial
residual heterozygosity following dichotomy of the strains.  Poor
breeding performance with small litter size.
Table 1.  Origin and characteristics of the three laboratory inbred strains used in this study.
84
4.1.2) Generation of inbred mice
Most breeding experiments usually start with an outcross, which is defined as the mating
between two animals or strains considered unrelated to each other. All members of an inbred
strain are homozygous across their entire genome and genetically identical to each other. The
outcross between two unrelated inbred strains will result in offspring called the first filial
generation (F1) and will be identical to each other with a heterozygous genome. The offspring
that will result from the mating of two F1 siblings will produce the second filial generation.
Unlike the F1 where all animals are identical to each other (when generated from a pair of
inbred strains), the animals in the F2 which result from an intercross three different genotypes
will be possible at every locus. At each subsequent filial generation, genetic homogeneity
among siblings will be slowly recovered in a process which id referred to as inbreeding. This
process leads to the production of inbred animals which will be genetically homogeneous and
homozygous at all loci. The International Committee on Standardized Nomenclature for Mice
has ruled that a strain of mice can be considered inbred at generation F20 (Silver 1995).
Outbred or random bred mice such as the MF1 or CD1 are sometimes used because they
exhibit hybrid vigor with long life spans, high disease resistance, early fertility, large and
frequent litters, low neonatal mortality, and rapid growth. The F1 offspring of an outcross
between an outbred and an inbred mouse will not be identical with one another. However, at
each subsequent filial generation, genetic homogeneity among siblings will be recovered
during the course of inbreeding.
4.1.3) Genetic background of the cystic fibrosis mouse models
Mouse models are used extensively in biomedical research. A major boost to the cystic
fibrosis disease research was given by the generation of various mouse models using gene
targeting in embryonal stem cells. Inbred mice which have been commonly used for
backcrosses are the C57BL/6 (Cftrtm2Hgu, Cftrtm1Kth, Cftrtm2Cam, Cftrtm3Bay, Cftrtm1Bay, Cftrtm1Unc,
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Cftrtm1Cam) ( Dickinson et al., 2002, Zeiher et al., 1995, Colledge et al., 1995, Hasty et al.,
1995, O´Neal et al., 1993, Snouwaert et al., 1992, Ratcliff et al., 1993), the BALB/c
(Cftrtm1Unc) (Snouwaert et al., 1992)  the FVB/N (Cftrtm1Eur) (van Doorninck et al., 1995).
Outbred mice have also been used in some models instead of inbred strains, such as the CD1
(Cftrtm1Hsc, Cftrtm1G551D) (Rozmahel et al., 1996, Delaney et al., 1996) and the MF1 (CftrTgH(neo
im)1Hgu, Cftrtm1Cam) (Dorin et al., 1992, Ratcliff et al., 1993).
4.1.4) Generation of congenic CF mouse models
The same Cftr mutations have been established on different inbred strains generating
congenic strains, introducing the possibility of comparing the effects of genetic differences
between the inbred strains and has facilitated the search for modifier genes.
Mice that have been bred to be essentially isogenic with an inbred strain except for a selected
differential chromosomal segment are called congenic strains. Congenic production utilises in
most cases the method known as the backcross or NX system. An outcross between the
recipient inbred partner and the animal that carries the donor allele, which can be either an
inbred or an outbred animal homozygous at the locus of interest, will result F1 animals 100%
heterozygous at all loci, in the case of an inbred partner. The second generation cross and all
those that follow are backcrosses to the recipient inbred strain. At each generation (Nn) the
offspring which carry the donor allele at the differential locus will be selected for the next
backcross. By the tenth generation (N10), the new strain is considered to be congenic (99%)
(Silver 1995).
Initial characterisation of the different CF mouse models did not put emphasis on the
background strain and its key role in phenotypic modification. The original study (Rozmahel
et al., 1996 ) on the mixed outbred F2 CD1/129-Cftrtm1Hsc animals differentiated the animals in
three different classes (Class I, II, III) depending upon when the mice died. Genetic
experiments can not be performed straight forward with an outbred strain such as the CD1
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since they are genetically non identical. To test the hypothesis of an unlinked modifier locus
the original founder mouse was backcrossed to three different inbred strains (C57BL/6J,
BALB/c, DBA/2J) generating congenic animals. Mortality varied significantly between the
three different inbred backgrounds and the candidate modifier locus was mapped (using
linkage analysis) on the proximal region of mouse chromosome 7 using dinucleotide repeats
(microsatellites).
4.1.5) Microsatellite markers
Microsatellites are small blocks of tandemly repeated DNA, in which the repeated element is
usually a di-, tri-, or tetranucleotide sequence. The class found most often in the mouse
genome contains a (CA)n (GT)n dimmer. The number of repeat elements in these blocks is
highly polymorphic, and shows simple Mendelian inheritance. Allelic variation is based on
differences in the number of repeats present in a tandem array and the only way in which
alleles can be distinguished is by measuring the total length of the microsatellite. Genotyping
of microsatellites is accomplished through PCR amplification with primers on the flanking
sequence on either side of the repeat, followed by denaturing gel electrophoresis
Microsatellites can be selected either manually by searching through sequence databases for a
(CA)n repeat and design flanking primers or select primers for known polymorphic
microsatellites via the Mouse Genome Database (www.informatics.jax.org ).
4.1.6) Genetic relationships between inbred strains
Establishment of the genetic profile of inbred strains can be used for the determination of
genetic relationships between different inbred strains. Inbred strains of mice are valuable
model organisms also for studies in evolutionary biology, particularly at the molecular level
(Atchley and Fitch 1991), as the genealogy of a number of genetically highly different strains
is known with considerable certainty. Knowledge of the genealogical relationships and of the
levels of genetic similarity helped researchers to evaluate the relative efficacy of various
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phylogenetic algorithms, to determine the relative information content of various types of data
and examine other biological phenomena by using taxa of known degrees of relatedness.
Moreover the extensive genetic data available at different levels of organisation that can be
used for phylogenetic analyses provided scientists with a useful tool with which evolutionary
studies can be efficiently carried out. These data include DNA sequences, simple-sequence-
length polymorphisms, restriction fragment length polymorphisms (RFLPs) mitochondrial
DNA (mtDNA), X- and Y-chromosome sequences (Dietrich et al., 1992, Tucker et al., 1992,
Atchley et al., 1993). Determination of the genealogical relationships among the available
strains of mice has been difficult. This is because during the early history of inbred mice,
mice from a small number of stocks held in a few laboratories (Cold Spring Harbor
Laboratories, Bussey Institute, Rockefeller Institute) had probably contributed considerably to
the genomes of the present day inbred strains of mice (Atchley et al., 1993). Determination of
phylogenetic affinities among inbred strains is becoming complicated by the fact that many
inbred strains include genetic components from different species, i.e., Mus musculus, M. m.
domesticus  and Mus. m. castaneus (Bonhomme et al., 1986, Tucker et al., 1992).
It can be important to have knowledge of genetic distances between strains, for choosing the
best possible stains for an experiment. Phenotypic differences between inbred strains need to
be taken into account when designing experiments. Strains may vary in characteristics that
may not be relevant to the phenotype being studied, but which may indirectly influence
experimental results. It is critical to have comprehensive data on the characteristics of the
background strain before assessing the phenotypic consequences of introducing mutations.
The relationships of the inbred strains of mice have been investigated using parsimony
analysis by Atchley and Fitch (1991), employing classical genotypes at 144 loci over the
whole genome. At each locus, possession by two strains of the same-sized allele indicates
probable similarity by descent of that sequence. Microsatellite data lend itself conceptually to
parsimony analysis because alleles differ by discrete steps (Weber et al., 1993, Amos et al.,
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1996, Primmer et al., 1998). Compared to methods based on a distance matrix, parsimony
allows more information to be considered in the analysis (Schalkwyk et al., 1999). The
Wagner parsimony method does not assume that the ancestral state is known or that mutation
in one direction is more probable than the other
89
4.2) Materials and Methods
4.2.1) Animals
All animals used in this study were bred under specified pathogen-free conditions in the
isolator unit of the Hannover Medical School Laboratory Animal Facilities. Mice were kept in
a flexible film isolator with a temperature maintained at 20-24ºC with 40-50% relative
humidity. Animals were fed an irradiated (50 kGy) standard chow (Altromin 1314) and
autoclaved water (134ºC for 50min) ad libitum.
All experiments were approved by the local Institutional Animal Care and Research Advisory
Committee and by the local government.
4.2.2) Generation of inbred CftrTgH(neo im)1Hgu mutant mice.
For the establishment of the inbred population of CftrTgH(neoim)1Hgu mice a mixed background
pair (generation F4) of one homozygous male and one homozygous female was obtained from
the MRC Human Genetics Unit, Edinburgh. Two separate litters were obtained and two
animals of each litter became the founders of the two individual inbred CftrTgH(neoim)1Hgu
strains CF/1- CftrTgH(neoim)1Hgu and CF/3- CftrTgH(neoim)1Hgu which were generated by strict
brother-sister mating for more than 26 generations.
4.2.3) Microsatellite selection
The primers flanking the microsatellite regions were obtained from the MGI database
(www.informatics.jax.org). Seventy eight microsatellite markers with at least two different
variants between the three inbred mouse strains, C57BL/6, DBA/2 and BALB/c were chosen
via the MGI database at about every 20cM. Polymorphic loci between the two inbred CF
strains were genotyped with markers flanking the informative loci in order to map the regions
of genetic heterogeneity. In total 105 misrosatellites were chosen for the 19 autosomal
chromosomes (Figure 1).
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D8Mit24
D8Mit204
D8Mit65
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D9Mit191
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Figure 6. Location of the SSLP typed in this study. Names of markers are abbreviated following the
rules and guidelines of the International Committee on Standardised Genetic Nonmenclature for mice
(www.informatics.org/nomen) whereby DNA segments are symbolised according to the laboratory
identifying or mapping the segment as “DNA segment, chromosome N, Lab name” and a serial
number, where N is the chromosomal assignment (1-19) and is symbolised as DNLabcode.
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D14Mit254
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Figure 6 (cont) For example: D13Mit3, is the 3rd locus mapped on chromosome 13 by M.I.T. For one
marker the laboratory designation is different: D14DNS1. Map scale is shown to the side of each
chromosome. Chromosomes 6, 8, 10, 11, 14, 15 and 18 were densely genotyped in order to map the
regions of genetic heterogeneity between CF/1 and CF/3.
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4.2.4) High molecular weight DNA isolation
High molecular weight DNA was isolated from spleen tissue (from ten CF/1, ten CF/3, two
BALB/c, two C57BL/6 and two DBA/2) either fresh or thawed on ice after storage at -20C
based on the protocol described by Gross and Bellard et al.(1973). The tissues were incubated
with 50ml lysis buffer (50mM Tris-HCl, 109.5g/l Saccharose, 1% w/v Triton X-100) for
30min on ice followed by centrifugation at 5000 x g for 15 minutes. The pellet was treated
with 40µl of 50mg/ml proteinase K, 200µl SDS 10% in STE and was allowed to incubate for
12 hours at 56ºC in a shaking water bath. Digested proteins and high molecular weight DNA
were separated two times with phenol/chloroform extraction: 3ml phenol and 3ml
chloroform/isoamylalchohol were added to the digest followed by a gentle mix for 10
minutes, centrifugation at 5000 x g for 10 minutes, and removal of the organic phase. This
extraction step was followed by a two times extraction with 6ml chloroform in order to
remove phenol remaining in the aqueous phase. DNA was precipitated by adding 1/10 of the
volume of the aqueous phase of 3M sodium carbonate (pH 5.5) and 30ml of 70% ethanol (-
20C). High molecular weight DNA was transferred into an Eppendorf cup containing 1ml of
70% ethanol and was further centrifuged at 13000 x g for 3 minutes. The resulting pellet was
washed with 70% ethanol two times and was allowed to dry at 37C for no more than 30
minutes, and dissolved in 1ml TE buffer at 4ºC.
4.2.5) Genotyping of microsatellites
4.2.5.1) PCR
All microsatellite markers were genotyped using PCR in 96 well plates (multiwell plates)
purchased from Greiner, Frickenhausen, precoated with 50ng of DNA template per well in a
Hybaid Thermocycler (Hybaid, Teddington) with a heated lid. One of the two primers per
microsatellite was 5´-terminal biotinylated and every PCR reaction was performed in a total
volume of 30µl, without oil overlay using InViTaq polymerase (InViTek, Berlin).Evaporation
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during the reaction was prevented with the use of PCR foil purchased by Eppendorf covering
the multiwell plate
4.2.5.2) Analysis of polymorphisms using direct blotting electrophoresis
After PCR an 8µl aliquot was transferred to a multiwell plate and allowed to dry overnight at
37ºC, dissolved in 10µl loading buffer (0.2% w/v xylenecyanol and bromphenolblue in
formamid) and denatured for 5min at 95ºC. The PCR products were separated by direct
blotting electrophoresis (GATC 1500, MWG Biotech, Ebersberg, Germany) on a denaturing
acrylamide gel (4% acrylamide/N,N’-methylenebisacrylamide 29:1 containing 6M urea in
0.9M Tris-0.9M Boric Acid-0.02M EDTA buffer) and simultaneously transferred to a
Hybond N+membrane (Amersham). Signals were visualised by blocking the membrane in 1.5
w/v of blocking reagent in Buffer I, followed by incubation in diluted solution of anti-biotin
alkaline phosphatase conjugate in Buffer I. The membrane was further washed three times
with 1% Triton X-100 in Buffer I and equilibrated for 15min in assay buffer (100mM Tris-
HCl, 100mM NaCl, 50mM MgCl2, pH 9.5). The membrane was covered for 5min with
reaction buffer containing 10%v/v Sapphire II (Tropix) and 60µl CDPstar (Tropix) in 50ml
assay buffer, followed by rinsing with a solution containing 1% v/v Sapphire II and 6µl
CDPstar in 50ml assay buffer. Membranes were sealed in polysterol-foil and
chemiluminescence was detected with Kodak X-o-mat X ray films. Exposition time varied
from 10min to 45min depending on the efficiency of the PCR.
4.2.6) Parsimony Analysis
Family tree was constructed using parsimony analysis with PHYLIP 3.6 (Felsenstein 1989).
To do parsimony analysis with PHYLIP 3.6 which accepts only binary discrete characters, the
microsatellite allele size data were recoded as letters (a-e), in such a way that (a) is always the
larger in size allele. Wagner parsimony analysis was done with the PARS program of
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PHYLIP 3.6 (Felsenstein 1989). The Wagner parsimony method does not assume that the
ancestral state is known or that mutation in one direction is more probable than the other.
For the analysis 91 out of the total of 105 genotyped loci were used, the program does not
identify gaps and therefore all microsatellites with a heterozygous result for the pool of CF/1-
CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu and those with alleles missing were excluded from
the analysis.
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4.3) Results and Discussion
The aim of this study was to identify the genome wide strain distribution pattern of
microsatellite alleles between the two inbred CF strains (CF/1- CftrTgH(neoim)Hgu, CF/3-
CftrTgH(neoim)Hgu) and the three inbred strains (C57BL/6, BALB/c, DBA/2J) which were used
for the generation of congenic strains.
4.3.1) Analysis of results
PCR amplification of microsatellites results in a number of ‘shadow bands’ both smaller and
larger than the true alleles by integral numbers of repeat units. Slipped band mispairing is
thought to be the major mechanism responsible for producing shadow bands at tandem
dinucleotide repeats (Litt et al., 1993, Murray et al., 1993, Hauge et al., 1993). Titration of the
number of PCR cycles and reduction of the primer concentration have been found to reduce
the intensity of these extra bands and improve the quality of the PCR product (Todd et al.,
1991).
Following direct blotting electrophoresis each allele is represented by a major band with
strong intensity and by a variable number of shadow bands with reduced intensity when
compared to the major band. Inbred strains are homozygous for all loci (isogenic), therefore
each marker tested for these mice was expected to be homozygous. Informative microsatellite
markers were chosen on the basis that they will present more than one allele between the three
established inbred strains (C57BL/6J, BALB/c, DBA/2J) consequently three different
genotypes were expected (following illustrating example). The alleles corresponding to the
two inbred CF strains CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu were identified based
on the alleles observed for the three inbred strains.
Example demonstrating interpretation of results
In order to genotype microsatellites, the repeat sequence is amplified via PCR, using primers
that bind next to the repeat and include it into the PCR product (NNNNN).
Allele c-Strain A
NNNNNNNNNNNNCACACACACACACACACACACANNNNNNNNNNNN
Allele b-Strain B
   NNNNNNNNNNCACACACACACACCACACACACACACACACACANNNNNNNNNN
Allele a-Strain C
         NNNNNNNNNCACAACACACACACACACACACACACCACACACACACACACANNNNNNNNNN
Amplification of repetitive sequences can be prone to the appearance of by-products despite
the amplification of specific primers (amplification slippage). Different alleles of a certain
marker display characteristic by-band patterns with each marker giving a characteristic pattern
of alleles. Inbred strains are homozygous for all loci (isogenic) therefore each marker tested
for these mice was expected to be homozygous. (Marker D6Mit236)
The alleles corresponding to the two inbred CF strains CF/1- CftrTgH(neoim)Hgu and CF/3-
CftrTgH(neoim)Hgu were analysed based on the allele pattern corresponding to the three inbred
strains.
Allele a
Allele b
Allele c
DBA/2J
C57BL/6
BALB/cDBA/2J
C57BL/6
BALB/c
CF/1, CF/396
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4.3.2) Strain distribution pattern between the two CF strains and the three wild type inbred
strains
In total 105 microsatellite markers were typed for the two inbred CF strains and the three
inbred wild type strains. The results are summarised in the table below.
Marker Chr. cM CF/1 CF/3 DBA/2 C57BL/6 BALB/c
D1Mit211 1 15 b (146) b (146) b (146) c (139) a (149)
D1Mit303 1 34.8 124/130 124/130 a (124) a (130) a (130)
D1Mit136 1 59.6 a (108) a (108) b (104) c (102) a (108)
D1Mit450 1 79 a (118) a (118) b (106) a (118) a (118)
D2Mit372 2 27.3 b (119) b (119) b (119) b (119) a (127)
D2Mit37 2 45 c (146) c (146) a (182) b (174) c (146)
D2Mit525 2 61.2 a (127) a (127) b (117) 0 a (125)
D2Mit285 2 86 0 b (150) d (138) a (152) c (148)
D3Mit130 3 3.9 a (140) a (140) c (121) b (123) c (121)
D3Mit96 3 23.3 b (221) b (221) a (225) c (211) a (225)
D3Mit156 3 45.2 c (254) c (254) a 266 d (252) b (260)
D3Mit254 3 64.1 a (150) a (150) c (128) a (150) b (138)
D3Mit163 3 87.6 a (147) a (147) a (147) 0 b (146)
D4Mit55 4 19.8 a (184) a (184) c (164) a (184) b (180)
D4Mit116 4 40 c (136) c (136) a (152) c (136) b (144)
D4Mit169 4 58 b (103) b (103) b (103) a (105) b (103)
D4Mit310 4 71 c (117) c (117) b (121 c (117) a (127)
D5Mit193 5 1 b (136) b (136) a (147) b (136) c (134)
D5Mit107 5 26 c (133) c (133) c (133) b (136) a (145)
D5Mit205 5 45 a (149) a (149) b (133) a (149) a (149)
D5Mit43 5 83 a (138) a (138) b (132) b (132) b (132)
D6Mit50 6 3.3 c (164) c (164) c (164) a (170) b (168)
D6Mit351 6 20.4 b (112) b (112) a (122) b (112) a (122)
D6Mit209 6 32 c (130) c (130) a (138) b (134) c (130)
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D6Mit69 6 35.15 c (144) c (144) a (168) b (164) c (144)
D6Mit263 6 37 b (144) a (168) a (168) b (144) b (144)
D6Mit284 6 37.50 136/142 136/142 c (136) a (145) e (133)
D6Mit67 6 41.50 a (158) a (158) d (148) c (152) b (156)
D6Mit108 6 48.10 a (141) a (141) c (129) b (131) c (129)
D7Mit152 7 1 b (130) b 130) d (123) c (127) a (133)
D7Mit229 7 23 a (143) a (143) a (143) b (139) c (123)
D7Mit216 7 44 b (184) b (184) a (186) c 180) b (184)
D7Mit330 7 57.5 b (124) b (124) a (134) b (124) a (134)
D7Mit109 7 66 a (120) a (120) c (108) b (118) b (118)
D8Mit143 8 8 a (279) a (279) b (269) a (279) a (279)
D8Mit289 8 11 a (158) a (158) d (148) c (152) b (156)
D8Mit4 8 14 d (157) b (197) c (195) d (157) a (200)
D8Mit24 8 18 a (168) a (168) a (168) b (160) 0
D8Mit204 8 20 a (150) a (150) a (150) b (148) a (150)
D8Mit65 8 22.5 a (280) a (280) b (234) b( 234) a (280)
D8Mit102 8 37 c (117) c (117) b (118) a (124) c (117)
D8Mit318 8 57 b (128) b (128) d (118) c (124) a (132)
D8Mit326 8 72 b (125) b (125) a (127) c (123) b (125)
D9Mit250 9 5 a (127) a (127) b (123) b (123) b (123)
D9Mit191 9 26 a (153) a (153) c (99) b (147) c (99)
D9Mit270 9 43 c (140) c (140) b (144) a (146) c (140)
D9Mit137 9 66 b (131) b (131) a (145) a (145) b (131)
D10Mit246 10 5 c (180) c (180) b (182) a (190) c (180)
D10Mit250 10 19 b (124) b (124) a (125) a (125) b (124)
D10Mit251 10 21 d (128) e (120) c (138) a (144) b (140)
D10Mit107 10 26 b (105) a (107) b (105) b (105) a (107)
D10Mit36 10 29 c (138) c (138) a (148) b (146) c (138)
D10Mit61 10 32 a (148) a (148) a (148) 0 a (148)
D10Mit261 10 47 a (114) a (114) c (104) b (110) d (108)
D10Mit103 10 70 b (144) b (144) c (142) d (140) a (146)
D11Mit2 11 2.4 b (122) b (122) a (124) b (122) c (112)
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D11Mit271 11 21 a (120) a (120) a (120) a (120) b (116)
D11Mit164 11 32 b (121) b (121) b (121) a (123) b (121)
D11Mit208 11 33 b (123) b (123) b (123) a (129) b (123)
D11Mit350 11 34.45 b (96) a (102) b (96) a (102) b (96)
D11Mit4 11 37 (244) (244/310) b (300) c (246) e (242)
D11Mit90 11 42 c (150) b (152) a (176) c (150) b (152)
D11Mit322 11 44 c (107) b (109) b (109) a (113) b (109)
D11Mit99 11 59 c (120) (120/123) c (120) a (124) b (123)
D11Mit49 11 77 b (156) b (156) b (156) a (158) a (158)
D12Mit37 12 1 a (140) a (140) a (140) a (140) b (118)
D12Mit153 12 15 a (160) a (160) b (158) d (142) d (156)
D12Mit159 12 38 a a a a a
D13Mit3 13 10 0 0 a (196) c (159) b (188)
D13Mit224 13 37 b (95) b (95) b (95) a (117) b (95)
D13Mit194 13 49 c (146) c (146) a (152) b (150) c (146)
D13Mit263 13 71 a (128) a (128) a (128) a (128) b (122)
D14Mit11 14 1 a (158) a (158) a (158) b (152) b (152)
D14NDS1 14 2.5 b (196) c (190) a (201) d (182) c (190)
D14Mit202 14 7 a (146) b (144) a (146) a (146) b (144)
D14Mit44 14 10 a (150) b (148) a (150) a (150) b (148)
D14Mit254 14 12 a (122) b (108) a (122) a (122) a (122)
D14Mit234 14 22.5 a (131) a (131) d (113) b (127) c (121)
D14Mit155 14 25 c (201) c (201) a (210) c (201) b (205)
D14Mit262 14 28.4 (154/158) c (154) c (154) d (124) b (156)
D14Mit237 14 32.5 b (125) a (134) b (125) b (125) b (125)
D14Mit239 14 42.5 c (125) c (125) a (131) b (129) c (125)
D14Mit106 14 48 c (307) b (309) c (307) a (312) c (307)
D14Mit166 14 52 (128/144) a (144) b (134) a (144) c (128)
D14Mit266 14 60 (176/180) (176/180) a (180) c (148) b (176)
D15Mit102 15 6.7 a (201) a (201) a (201) a (201) b (188)
D15Mit100 15 21.1 a (129) a (129) c (113) d (111) b (127)
D15Mit61 15 26 a (100) a (100) b (98) a (100) a (100)
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D15Mit46 15 27.5 c (142) d (140) a (152) b (150) e (138)
D15Mit270 15 28.4 a (200) a (200) b (188) a (200) c (180)
D15Mit144 15 32 c (127) c (127) a (145) c (127) b (143)
D15Mit70 15 47.7 a (152) a (152) b (144) a (152) b (144)
D15Mit35 15 61.7 a (146) a (146) c (136) b (142) a (146)
D16Mit146 16 16.9 b (120) b (120) b (120) a (123) a (123)
D16Mit76 16 43 a (108) a (108) a (108) b (89) a (108)
D17Mit117 17 29.4 a (127) a (127) a (127) b (123) a (127)
D17Mit142 17 47.4 (123/128) c (123) c (123) a (147) c (123)
D18Mit18 18 2 b (142) b (142) a (144) a (144) c (140)
D18Mit110 18 4 d (127) a (153) a (153) b (149) c (133)
D18Mit21 18 6 c (134) b (136) c (134) c (134) a (140)
D18Mit34 18 12 c (128) c (128) a (138) b (134) c (128)
D18Mit54 18 26 c (144) c (144) c (144) a (148) b (146)
D18Mit8 18 47 a (77) a (77) a (77) b (75) c (71)
D19Mit68 19 6 a (136) a (136) b (132) a (136) c (122)
D19Mit40 19 25 a (112) a (112) b (106) a (112) c (102)
Table 2. Strain distribution pattern between the three inbred strains (C57BL/6, BALB/c,
DBA/2J) and the two inbred CF lines (CF/1- CftrTgH(neoim)Hgu, CF/3- CftrTgH(neoim)Hgu) with 105
microsatellite markers. Letters represent alleles and allele size is in alphabetical order with a
used for the longest allele. The size of the fragment in basepairs is also indicated in
parenthesis. The thick black lines are used in order to separate the results between different
chromosomes. Marker sizes indicated in the table with underlined italic bold (i) characters,
are those found polymorphic between the two inbred CF strains (n=13). Those markers typed
in order to refine the polymorphic loci between the two CF strains are indicated by grey boxes
(  ).  Six alleles represented by 0 did not amplify and for D12Mit159 allele size could not be
assigned for any of the five alleles based on the given size on the database. For eight markers
heterozygosity was documented (in bold) and for 19 markers the observed allele size did not
agree with the allele size documented in the database for the same strains (indicated with bold
letters in the table).
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4.3.3) Analysis of the results for CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu
4.3.3.1) Informative microsatellites between the two inbred CF strains.
Sixteen markers out of 105 microsatellites typed were polymorphic between the two CF
strains (CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu) indicating that these two strains are
not identical to one another at all loci. This could be a direct impact of the inbreeding
procedure which was used in order to generate these two strains. The outcross at the
beginning of the inbreeding of the two CF strains was between outbred animals since the
founder animal was generated using the outbred MF1 strain. During inbreeding random
segregation and independent assortment will lead to animals in each generation that are
genotypically distinct. When two siblings are chosen randomly to become the parents of the
next generation there is the probability that they will be identically homozygous for a
particular locus (0.25), homozygous for a different allele (0.25) or identically heterozygous
(0.5). Depending on which animals in each generation are chosen for a subsequent breeding is
as to which parental allele will be fixed i.e. become homozygous and will remain fixed as
long as the brother x sister mating continues, except that mutations occur at this locus.
4.3.3.2) Heterozygosity
Residual heterozygosity was detected for eight microsatellites, between the two inbred CF
strains (CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu) indicating that the two strains were
still segregating at F22+. After 20 generations of brother x sister mating, a certain percentage
of loci will remain heterozygous this is because linked loci do not assort independently,
instead large chromosomal segments are inherited as units varying from one generation to the
next. By 60 generations of inbreeding or higher mice can be considered homozygous with a
probability of 99% in case there is no selection mutation (Silver 1995).
4.3.4) Stability of the inbred stains.
Fragment size of 19 microsatellite markers genotyped for the three inbred strains were
different from the fragment size indicated in the database. This verifies the fact that there is a
certain degree of genetic divergence between inbred strains maintained in different institutes.
The reason for this observed difference may be due to mutations which had no visible effect
on the phenotype and therefore remained undetected and became fixed in a homozygous state
through consecutive inbreeding.
4.3.5) Comparison of strain distribution patterns.
4.3.5.1) Comparison of the three inbred strains (C57BL/6, BALB/c and DBA/2J).
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Comparison of CF/1, CF/3 with C57BL/6
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alleles between the three inbred strains) 59 out of the total 105 (56%) markers were
polymorphic between the three inbred strains confirming previous findings of considerable
allelic variation between microsatellites of different inbred strains of mice (Mc Pherson 1996)
4.3.5.2) Comparison of the two inbred CF strains and the three inbred wild type strains.
CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu show considerable allelic variation when
compared with either one of the three inbred strains (Figure 3, Figure 4, Figure 5).
Figure 3. Comparison of microsatellite markers shared between CF/1, CF/3 and C57BL/6. (= same;
<> different). 24/105 were shared between all three strains whereas the majority of the satellites
58/105 were shared between CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu and were different with
C57BL/6. 12/105 were polymorphic between all three strains. C57BL/6 shared 9/105 with CF/1-
CftrTgH(neoim)Hgu and 2/105 with CF/3- CftrTgH(neoim)Hgu from the polymorphic markers between the two
inbred CF strains.
58/105 microsatellites were variable in size with the C57BL/6, 52/105 with the BALB/c and
58/105 with DBA/2J. This variation is comparable with the variation observed between the
three inbred strains (58/105), indicating that the inbreeding procedure which gave rise to the
two inbred CF strains resulted in mouse strains with a high degree of genetic variability when
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Figure 4. Comparison of microsatellite markers shared between CF/1- CftrTgH(neoim)Hgu, CF/3-
CftrTgH(neoim)Hgu and BALB/c. (= same; <> different). 30/105 were shared between all three strains
whereas the majority of the satellites 52/105 were shared between CF/1- CftrTgH(neoim)Hgu and CF/3-
CftrTgH(neoim)Hgu and were different with BALB/c.11/105 were polymorphic between all three strains.
BALB/c shared 5/105 with CF/1- CftrTgH(neoim)Hgu and 7/105 with CF/3- CftrTgH(neoim)Hgu from the
polymorphic markers between the two inbred CF strains.
compared with the three established laboratory strains. CF/1- CftrTgH(neoim)Hgu and CF/3-
CftrTgH(neoim)Hgu are the result of an inbreeding procedure at the beginning of which the
outcross was between outbred animals since the founder animal was generated using the
outbred MF1. The microsatellite allelic distribution of the MF1 mouse stock can not be
investigated since in non isogenic mouse strains, mice are not identical with each other and an
intrastrain allelic variability puts a restrain in the analysis of the resulting strain distribution
pattern.
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Figure 5. Comparison of microsatellite markers shared between CF/1- CftrTgH(neoim)Hgu, CF/3-
CftrTgH(neoim)Hgu and DBA/2J. (= same; <> different). 24/105 were shared between all three strains
whereas the majority of the satellites 58/105 were shared between CF/1- CftrTgH(neoim)Hgu and CF/3-
CftrTgH(neoim)Hgu and were different with DBA/2J. 9/105 were polymorphic between all three strains.
DBA/2J shared 9/105 with CF/1- CftrTgH(neoim)Hgu and 5/105 with CF/3- CftrTgH(neoim)Hgu from the
polymorphic markers between the two inbred CF strains.
One can only speculate that the considerable amount of genetic variation on the DNA level
observed between the two CF strains and the inbred strains investigated in this study is the
result of genetic difference between the outbred MF1 stock, and 129P2 (source of ES) with
the three inbred strains.
Sequence variations between the laboratory strains as detected by restriction enzymes is
difficult to find. The aim of this study was to identify the strain distribution patern between
the two CF strains and further between the three inbred strains before the analysing the
introgressed CftrTgH(neoim)Hgu mutation in the three inbred backgrounds B6.129P2(CF/3)-
CftrTgH(neoim)Hgu, C.129P2(CF/3)-CftrTgH(neoim)Hgu and D2.129P2(CF/3)-CftrTgH(neoim)Hgu animals.
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4.3.6) Family tree by parsimony analysis
Although there are now many microsatellite markers available (primarily MIT markers from
Dietrich et al., 1996) and the average density is about four markers/cM, it is quite often
difficult to find sufficient polymorphic markers for a particular pair of inbred strains. To
facilitate whole-genome scan experiments for the two inbred CF strains, CF/1- CftrTgH(neoim)Hgu
and CF/3- CftrTgH(neoim)Hgu, and the three inbred strains BALB/c, C57BL/6 and DBA/2J a
panel of 105 microsatellite markers were selected for this study on the basis of spacing and
polymorphism between the three inbred strains. CF/1- CftrTgH(neoim)Hgu and CF/3-
CftrTgH(neoim)Hgu have not been characterised previously with any of these markers. In order to
gain more information on the interrelationship of the two inbred CF strains and the three
inbred strains the results obtained from the whole genome scan for all five strains were used
for a parsimony analysis. Microsatellites offer a widely dispersed, selectively neutral set of
characters that lends itself conceptually to parsimony analysis (Schalkwyk et al., 1999,
Witmer et al., 2003,). Information on the interrelationships of strains is useful because of the
importance of polymorphism in designing crosses and the background in assessing
phenotypes. Atchley and Fitch (1993) performed a phylogenetic analysis employing classical
genotypes from 144 gene loci in 24 inbred mouse strains, using parsimony analysis.
Schalkwyk et al., (1999) performed a similar analysis using data from 128 SSLP loci in 11
inbred strains. Witmer et al., (2003) used the allele size data for 314 markers for 54 strains
and constructed a mouse family tree using Wagner parsimony analysis.
Using the results of 91 of the 105 loci spread over the genome a phylogenetic tree was
constructed representing the relationship of the two inbred CF strains and the three inbred
strains. X and Y chromosomes were not considered in this analysis. Most new mutations in
microsatellite markers (SSLP) are thought to result from gain or losses of a single repeat unit
(Weber and Wong 1993, Amos et al., 1996, Primmer et al., 1998). Multiple repeat units can
be added or deleted between alleles, and sometimes the entire repeat is duplicated. Parsimony
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analysis considers specific mutation steps rather than the simple proportion of alleles that are
the same size or different for a given marker. It assumes that species and characters evolve
independently, it does not assume that the ancestral state is known or that mutation in one
direction is more probable than the other. As in previous analyses without a defined model for
the process of addition or deletion of multiple repeat units it was not clear how this process
might affect the analysis. For the parsimony analysis in this study allele sizes were coded as
letters (a-e) without assuming that a particular allele is ancestral. Wagner parsimony analysis
using the PARS program of PHYLIP 3.6 (Felsenstein 1989), was performed. User options
were selected to generate an unrooted tree because of a) low marker size b) no ancestral state
for allele sizes was assumed for analysis. A consensus family tree is shown in Figure 6.
This tree has four groups of branches, labelled 1 to 4. Group 1 is comprised from the two
inbred CF strains CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu. Group 2 contains
C57BL/6, group 3 contains DBA/2J and group 4 contains BALB/c.
For the three inbred strains C57BL/6, BALB/c and DBA/2J the tree derived is largely
congruent with expectations from the known history of the strains and with the analyses of
Atchley and Fitch (1993), Shalkwyk et al., (1999) and Witmer et al., (2003) indicating that
the observed branching order is not the result of a subset of the recorded data which was
collected for a different purpose. The two inbred CF strains CF/1- CftrTgH(neoim)Hgu and CF/3 -
CftrTgH(neoim)Hgu which derived from the same founding pair form a strongly supported group
not distant from each other but distant from the other three groups. These results are strongly
supported by the microsatellite data but to make the picture more complete a larger number of
markers would be necessary.
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Figure 6. Family tree. Mouse strains are organised into 4 groups of branches. Group 1:CF/1 and CF/3;
Group 2: C57BL/6; Group 3: DBA/2J; Group 4: BALB/c. The length and angles of the branches are
optimised for printing and are not quantitative measures of evolutionary distance between strains.
4.5) Conclusions.
At present several models of CF have been described in the literature, however, one can not
easily make comparisons on these animal models because of a) differences in the mutation
induced to disrupt the murine Cftr gene on different genetically defined backgrounds; and b)
different controlled environmental factors (diet, housing conditions). The ability to place
(introgress) mutations on a different genetic background under the same housing conditions
does not only help to bypass obstacles mentioned above but makes it possible to dissect the
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role of the mutation induced, from the genetic background, and study the effect of modifier
genes. However, before embarking in such backcrosses one has to pay attention on the genetic
relationships of the strains that will be used for the generation of congenic animals and choose
those which are not so closely related. In this study microsatellite genome scan of the two
inbred CF strains and the three wild type standard strains revealed a high degree of difference
between their genetic backgrounds, making the three inbred strains good candidates for the
generation of congenic animals whereby genetic background based phenotypic differences
can be studied.
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Summary
 The laboratory mouse has played a key role in biomedical research. The
development of mouse models for cystic fibrosis (CF) has provided the
opportunity to dissect disease pathogenesis, correlate genotype and phenotype,
study disease-modifying genes and develop novel therapeutics.
Characterisation of the different CF mouse models has demonstrated the same
primary phenotypes which included intestinal obstruction and characteristic
intestinal and airway electrophysiology. Phenotypic variations between those
various mouse models have been shown to relate either to the specific
mutation, to different environmental influences and on independently
segregating modifier genes. In Chapter 1 an overview of these various mouse
models and their phenotypes is given.
 In order to dissect the role of the mutation from the genetic background CF/3-
CftrTgH(neoim)Hgu mice served as donors for the development of the three
congenic strains C57BL/6, BALB/c and DBA/2J, with selection for
CftrTgH(neoim)Hgu for 10 generations. Genotyping of the insertion mutation was
conducted by Southern analysis of XbaI/SalI restricted genomic DNA from
spleen. In Chapter 2 the introduction of an alternative genotyping technique
utilising informative Cftr intragenic microsatellite markers in order to follow
germline transmission of the mutated Cftr locus in the three inbred
backgrounds was described. Utilisation of this “high-throughput” PCR based
protocol provided a useful means whereby unidentified events such as
recombination and vector excision could be monitored.
 In Chapter 3 the phenotypic characterisation of the two inbred CF strains CF1-
CftrTgH(neoim)Hgu and CF3- CftrTgH(neoim)Hgu is described. Quantification of the
amounts of wild type Cftr protein produced by the two inbred CF strains was
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carried out using western blot analysis and the CFTR-specific antibody R3195.
The result indicated that both CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu
produce reduced amounts of wild type protein. Overall the electrophysiological
profile of the two stains was indistinguishable and argued for amelioration of
the CF basic defect in these mice. Based on these phenotypic observations
CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu mice provide excellent models
for the identification of those genetic factors which influence disease
phenotype and relate to those cellular processes which are involved in both the
transcriptional and translational level influencing both mRNA and protein
processing.
 In Chapter 4 the genetic characterisation of the two inbred CF strains and the
three inbred wild type standard inbred strains is described. A genome scan was
performed for the five strains with 105 polymorphic DNA markers. The two
inbred CF strains showed considerable allelic variation when compared with
either one of the three inbred strains. This high degree of discordance (60%)
between the genetic backgrounds of the strains used in this study may provide
a useful tool for the interpretation of putative phenotypic differences which
may account for the three congenic strains in the future. Hence, assisting in the
identification of those factors which influence the phenotypic outcome
observed for CF/1- CftrTgH(neoim)Hgu and CF/3- CftrTgH(neoim)Hgu in Chapter 3.
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Appendix
1.1 Abbreviations
APS Ammoniumperoxodisulfate
ATP adenosine triphosphate
BALF bronchoalveolar lavage fluid
BBMV brush border membrane vesicles
CHO Chinese hamster cells
CF Cystic Fibrosis
CFTR Cystic Fibrosis Transmembrane Conductance Regulator
DEPC 4,4´diisothiocyanatostilbene-2,2´-disulfonic acid
DNA deoxyribonucleic acid
EDTA ethylenediamine tetraacetate
ER endoplasmic reticulum
LPS lipopolysaccharide
MI meconium ileus
MMR mismatch repair
NBD nucleotide binding domain
NER nucleotide exchange repair
NMD nonsense mediated decay
PA Pseudomonas aeruginosa
PCR Polymerase Chain Reaction
PKA protein kinase A
RFLP Restriction Fragment Length Polymorphism
RNA ribonucleic acid
SCC short circuit current
SNP Single Nucleotide Polymorphism
SPF Specific pathogen free
TNF-α tumour necrosis factor alfa
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1.2 Material and equipment
1.2.1 Membrane, X-ray films
Hybond N+ Nylon membrane Amersham, Freiburg, D
KodakX-o-Mat AR X-ray films Eastman Kodak, New Haven, CT, USA
1.2.2 Technical equipment
Autoclave Tuttnauer, Breda, NL
Centrifuges:
-Beckman GS-15R Beckman Coulter, Fullerton, CA, USA
-Beckman Microfuge R Beckman Coulter, Fullerton, CA, USA
-Eppendorf Mini Spin Plus Eppendorf, Hamburg, D
Direct Blotter
-GATC1500 direct blotting GATC, Konstanz, D
electrophoresis sequencer
Gel chambers for agarose electrophoresis Forchungswerkstätten, MH Hannoner
Gel documentation system:
-Gel-Print 2000 Biophotonics, Ann Arbor, MI, USA
Pippetes:
-Mechanical Eppendorf, Hamburg, D
Gilson, Villier le Bel, F
SLG, Gauting, D
- Multiwell Biozym, Hess, Oldendorf, D
Eppendorff, Hamburg, D
Photometer Hitachi, Tokyo, J
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Power supplies BioRad, Hercules, CA, USA
Scales Sartorius, Göttingen, D
Thermocycler Hybaid, Teddington, UK
Thermomixer Eppendorf, Hamburg, D
UV translluminator Bachofer, Reutlinger, D
1.2.3 Consumables
Filter pipette tips (sterilile) Greiner Bio-One, Frickenhausen, D
Latex exam Gloves (powder free) Kimberly Clark, Zaventem, B
Multiwell PCR Plates Greiner.Bio-One
Pipette tips Eppendorff, hamburg, D
Sarstedt, Nümbrecht, D
Reaction vials Eppendorff, Hamburg, D
Sarstedt, Nümbrecht, D
1.2.4 Chemicals
1.2.4.1 General Chemicals
Acrylamide:
-AccuGel 19:1 National Diagnostics Atlanda, Georgia, USA
-Rotiphorese Gel 40 Roth, Karlsruhe, D
Agarose ultra pure Life Technologies, Paisley, Scotland, UK
Ammoniumperoxodisulfate (APS) Roth, Karlsruhe, D
Boric acid, crystalline (H3BO3) Merck, Darmstadt, D
Bromphenolblue Serva, Heidelberg, D
Diethyl-pyrocarbonate (DEPC) Sigma-Aldrich, Steinheim, D
Chloroform p.a Roth, Karlsruhe,D
Acetic Acid, 96% Merck, Darmstadt, D
Ethanol JT Baker, Deventer, NL
Formamide Sigma-Aldrich, Steinheim, D
Glycerol Fluka, Buch, CH
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Isomylalcohol Roth, Karlsruhe,D
Isopropanol Fluka, Buch, CH
KCl, p.a Merck, Darmstadt, D
MgCl2 x 6 H2O, p.a Merck, Darmstadt, D
NaCl, p.a Merck, Darmstadt, D
NaOH, p.a Merck, Darmstadt, D
Na2-EDTA Merck, Darmstadt, D
Paraffin Fluka, Buch, CH
Phenol:
-Roti-Phenol pH 7.5-8.0 Roth, Karlsruhe
TEMED Serva, Heidelberg, D
Tris ultra pure ICN, Aurora, Ohio, USA
Triton x 100 Serva, Heidelberg, D
Urea, pearls, purest Merck, Darmstadt, D
Xylenecyanol Sigma, St.Louis, MO, USA
1.2.4.2 Buffers and standard solutions
Developing Buffer I:
100mM Tris-HCl pH 7.5
150mM NaCl
Developing Buffer III:
100mM Tris-HCl pH 9.5
100mM NaCl
50mM MgCl2
Loading buffer for agarose gels:
0.05% (w/v) xylenecyanol, 0.05% (w/v) bromphenolblue, 40% (w/v) glycerol
Loading buffer for direct dlotter:
0.2% (w/v) xylencyanol, 0.2% (w/v) bromphenolblue in formamide
Lysis buffer:
50mM Tris-HCl pH 7.5
109.5 g/l saccharose
1% (w/v) Triton X-100
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STE:
50mM Tris-HCl pH 7.5
100mM NaCl
1mM Na2-EDTA
10 x TBE:
1.275M Tris-HCl pH 9.0
0.42M H3BO3
0.024M Na2-EDTA
TE:
10mM Tris-HCl pH 8.0
1 mM Na2-EDTA
1.2.4.3 Biochemicals, enzymes, enzyme-related buffers and photo-chemicals.
Anti-Biotin-AP, Fab-fragments Roche Diagnostics, Mannheim, D
Blocking Reagent Roche Diagnostics, Mannheim, D
CDP star Tropix, Bedford, MA, USA
Developing solution for X-ray films Agfa-Gevaert, Mortsel, B
Desoxynucleotides (dNTPs) Roth, Karlsruhe, D
Express fixative salt Tetenal, Norderstedt, D
Luminescence-enchancer Sapphire II Tropix, Bedford, MA, USA
Oligonucleotides Invitrogen, Life technologies, Paisley, UK
Restriction enzymes New England Biolabs, Frankfurt/Main, D
Taq polymerase InviTek, Berlin, D
dNTPs:
100 mg dNTP (A,G,C or T)
+100 µl Tris-HCl 1M pH 7.0
+900 µl H2OSTE
add 1.1 ml H2OSTE
2 µM of each dNTP was added together and filled up to 1ml with H2OSTE resulting in a dNTP premix solution
with a final concentration of 2mM of each dNTP.
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PCR 10 x NH4+ reaction buffer (InviTek).
500 mM Tris-HCl pH 8.8
160 mM (NH4)2SO4
0.1% Tween 20
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